datetime,channel,message_id,url,raw,lm_json
2025-12-10T14:35:19+00:00,@bezrec,6918,https://t.me/bezrec/6918,"–§–ê–° –∏–∑–º–µ–Ω–∏–ª–∞ –ø–æ–∑–∏—Ü–∏—é –ø–æ –∞–∫—Å–∏—Ç–∏–Ω–∏–±—É, –¥–∞–ø–∞–≥–ª–∏—Ñ–ª–æ–∑–∏–Ω—É, —Ä—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–±—É –∏ –æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±—É. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –æ—Ç–∑—ã–≤–∞—é—Ç –ø–∏—Å—å–º–∞, –≤ –∫–æ—Ç–æ—Ä—ã—Ö —Ä–∞–∑—ä—è—Å–Ω—è–ª–∏ –≤–æ–ø—Ä–æ—Å —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è –∑–∞—è–≤–æ–∫ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –∑–∞–∫—É–ø–æ–∫, –ø—Ä–µ–¥–ª–æ–∂–∏–≤—à–∏—Ö –∫ –ø–æ—Å—Ç–∞–≤–∫–µ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ —Å –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã–º–∏ –¥–µ–π—Å—Ç–≤—É—é—â–∏–º–∏ –≤–µ—â–µ—Å—Ç–≤–∞–º–∏. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ, –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –æ—Ç–∫–ª–æ–Ω—è—Ç—å —Ç–∞–∫–∏–µ –∑–∞—è–≤–∫–∏ –±–æ–ª—å—à–µ –Ω–µ—Ç. –ù–∞–ø–æ–º–Ω–∏–º, –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –ú–æ—Å–∫–≤—ã –æ—Ç–º–µ–Ω–∏–ª —Ä–µ—à–µ–Ω–∏–µ –§–ê–°, –∑–∞–ø—Ä–µ—â–∞—é—â–µ–µ ¬´–ê–∫—Å–µ–ª—å—Ñ–∞—Ä–º—É¬ª –≤—ã–≤–æ–¥–∏—Ç—å –Ω–∞ —Ä—ã–Ω–æ–∫ —Å–≤–æ–π —Ä—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–± –∏–∑-–∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏—è –∑–∞–∫–æ–Ω–∞ –æ –∑–∞—â–∏—Ç–µ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏. –†–∞–Ω–µ–µ –∫–æ–º–ø–∞–Ω–∏–∏ —É–¥–∞–ª–æ—Å—å –æ—Å–ø–æ—Ä–∏—Ç—å –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–µ –ø—Ä–µ–¥–ø–∏—Å–∞–Ω–∏—è —Å–ª—É–∂–±—ã –ø–æ –¥–∂–µ–Ω–µ—Ä–∏–∫—É –ò–Ω–ª–∏—Ç—ã (–∞–∫—Å–∏—Ç–∏–Ω–∏–±) –æ—Ç Pfizer –∏ –∞–Ω–∞–ª–æ–≥—É –¢–∞–≥—Ä–∏—Å—Å–æ (–æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±) –æ—Ç AstraZeneca. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""The FAS has changed its position regarding axitinib, dapagliflozin, ruxolitinib, and osimertinib. Antimonopoly authorities are withdrawing letters explaining the review of tender applications that proposed to supply generics with these active substances. As a result, there is no longer a need to reject such applications. Previously, the Moscow Arbitration Court overturned a FAS decision banning Axelson from entering the market with its ruxolitinib due to a violation of competition protection laws. Earlier, the company successfully challenged similar orders by the generics service for Inlyta (axitinib) from Pfizer and Tagrisso (osimertinib) from AstraZeneca.""
}"
2025-12-10T12:00:15+00:00,@bezrec,6917,https://t.me/bezrec/6917,"–ê–Ω–∞–ª–∏—Ç–∏–∫–∏ –≤—ã—è—Å–Ω–∏–ª–∏, –∫–∞–∫ –∏–¥—É—Ç –¥–µ–ª–∞ –Ω–∞ —Ä—ã–Ω–∫–µ –∞–Ω—Ç–∏–∫–æ–∞–≥—É–ª—è–Ω—Ç–æ–≤. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ 58,3 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –∞–Ω—Ç–∏—Ç—Ä–æ–º–±–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –Ω–∞ 49,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 6,3% –±–æ–ª—å—à–µ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –∏ –Ω–∞ 1,7% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –ë–æ–ª–µ–µ 57% –¥–µ–Ω–µ–∂–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂ –≤ –≥—Ä—É–ø–ø–µ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –ø—Ä—è–º—ã–µ –∏–Ω–≥–∏–±–∏—Ç–æ—Ä—ã —Ñ–∞–∫—Ç–æ—Ä–∞ –•–∞, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã–µ —Ç—Ä–µ–º—è –ú–ù–ù. –≠—Ç–∞ –∂–µ –∫–∞—Ç–µ–≥–æ—Ä–∏—è –æ—Ç–ª–∏—á–∏–ª–∞—Å—å –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö (+16%). –í –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–π —Å—Ç–µ–ø–µ–Ω–∏ —É—Å–ø–µ—Ö—É —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Ä–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω–∞, –≥–¥–µ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–∏ –∞–∫—Ç–∏–≤–Ω–æ –ø–µ—Ä–µ–∫–ª—é—á–∞—é—Ç—Å—è —Å –ø–æ—Ç–µ—Ä—è–≤—à–µ–≥–æ –ø–∞—Ç–µ–Ω—Ç–Ω—É—é –∑–∞—â–∏—Ç—É –ö—Å–∞—Ä–µ–ª—Ç–æ –æ—Ç ¬´–ë–∞–π–µ—Ä¬ª –Ω–∞ –ø—Ä—è–º—ã–µ –∞–Ω–∞–ª–æ–≥–∏. –ü–æ –∏—Ç–æ–≥–∞–º –∞–≤–≥—É—Å—Ç–∞ 2025 –≥–æ–¥–∞ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ —É–∂–µ –æ–ø–µ—Ä–µ–¥–∏–ª–∏ –ø–æ –ø—Ä–æ–¥–∞–∂–∞–º –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç. –ù–∞ —ç—Ç–æ–º —Ñ–æ–Ω–µ —Ä–∞—Å—Ç—É—Ç –æ–±—ä—ë–º—ã –ø—Ä–æ–¥–∞–∂ –≠–ª–∏–∫–≤–∏—Å–∞ –æ—Ç ¬´–ü—Ñ–∞–π–∑–µ—Ä¬ª. –û—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –∏–Ω–≥–∏–±–∏—Ç–æ—Ä —Ñ–∞–∫—Ç–æ—Ä–∞ –•–∞ ‚Äî –î–∏–º–æ–ª–µ–≥–∏–Ω –æ—Ç ¬´–ê–≤–µ–∫—Å–∏–º–∞¬ª ‚Äî –ø–æ–∫–∞ –≤ —Ç–æ–ø-10 –Ω–µ –≤–æ—à—ë–ª. –ß—Ç–æ–±—ã –¥–æ–±–∏—Ç—å—Å—è —É—Å–ø–µ—Ö–∞ –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏, –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é –Ω—É–∂–Ω–æ –±—É–¥–µ—Ç —Å–µ—Ä—å—ë–∑–Ω–æ –≤–ª–æ–∂–∏—Ç—å—Å—è –≤ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ. –†–æ—Å—Ç —Å–ø—Ä–æ—Å–∞ —Ç–∞–∫–∂–µ –Ω–∞–±–ª—é–¥–∞–ª—Å—è –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –≥–µ–ø–∞—Ä–∏–Ω–æ–≤ (+9%), –Ω–æ —Å—É–º–º–∞—Ä–Ω—ã–π –æ–±—ä—ë–º –∏—Ö –ø—Ä–æ–¥–∞–∂ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –ø—Ä–∏–º–µ—Ä–Ω–æ –≤ 12 —Ä–∞–∑ –º–µ–Ω—å—à–µ, —á–µ–º —É –∞–ø–∏–∫—Å–∞–±–∞–Ω–∞ –∏ —Ä–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω–∞. –¢–∞–∫, –ö–ª–µ–∫—Å–∞–Ω (—ç–Ω–æ–∫—Å–∞–ø–∞—Ä–∏–Ω–∞ –Ω–∞—Ç—Ä–∏—è) –æ—Ç ¬´–°–∞–Ω–æ—Ñ–∏¬ª –∑–∞ –≥–æ–¥ –ø—Ä–∏–±–∞–≤–∏–ª 25% –≤ —Ä—É–±–ª—ë–≤–æ–º —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–µ –∏ 19% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º. –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–∫–∞–∑–∞–ª–∏ –∏–Ω–≥–∏–±–∏—Ç–æ—Ä—ã –∞–≥—Ä–µ–≥–∞—Ü–∏–∏ —Ç—Ä–æ–º–±–æ—Ü–∏—Ç–æ–≤ ‚Äî –∞–±—Å–æ–ª—é—Ç–Ω—ã–π –ª–∏–¥–µ—Ä —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è. –û–±—â–µ–µ –ø–∞–¥–µ–Ω–∏–µ —Å–ø—Ä–æ—Å–∞ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ —Å–≤—è–∑—ã–≤–∞—é—Ç —Å —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ–º –ø—Ä–æ–¥–∞–∂ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∞—Ü–µ—Ç–∏–ª—Å–∞–ª–∏—Ü–∏–ª–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç—ã. –¢–∞–∫–∂–µ –≤ —Ç–æ–ø-10 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –∞–Ω—Ç–∏—Ç—Ä–æ–º–±–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ–ø–∞–ª–∏: –ö–∞—Ä–¥–∏–æ–º–∞–≥–Ω–∏–ª (¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª), –í–µ—Å—Å–µ–ª –î—É—ç –§ (¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞¬ª), –ö–ª–æ–ø–∏–¥–æ–≥—Ä–µ–ª (¬´–°–µ–≤–µ—Ä–Ω–∞—è –∑–≤–µ–∑–¥–∞¬ª + 17 –∫–æ–º–ø–∞–Ω–∏–π), –ü—Ä–∞–¥–∞–∫—Å–∞ (¬´–ë–µ—Ä–∏–Ω–≥–µ—Ä –ò–Ω–≥–µ–ª—å—Ö–∞–π–º¬ª), –ë—Ä–∏–ª–∏–Ω—Ç–∞ (¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞¬ª), –¢—Ä–æ–º–±–æ –ê–°–° (¬´–ë–∞—É—à –•–µ–ª—Å¬ª), –†–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω (¬´–í–µ—Ä—Ç–µ–∫—Å¬ª + 17 –∫–æ–º–ø–∞–Ω–∏–π). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""demand, clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Analysts have examined the market situation for anticoagulants. According to RNC Pharma data, in Russia, sales of antithrombotic drugs increased by 6.3% in monetary terms and 1.7% in physical units this year, totaling 58.3 million packages and 49.3 billion rubles. The majority (over 57%) of the monetary volume is accounted for by direct inhibitors of factor X, with three main drug names. This category showed the highest growth rate in terms of packages (+16%). The success was mainly due to rivaroxaban drugs, where consumers are actively switching from Bayer's patented Ksarelto to direct analogues. By August 2025, generics have already surpassed the sales volume of the original drug. Pfizer's Ellicvis also saw a rise in sales. Original Russian inhibitor factor X ‚Äî Dimolgin from Avexima ‚Äî has not yet entered the top-10. To achieve success in this category, manufacturers need to significantly invest in promotion. Sales"
2025-12-10T09:02:35+00:00,@bezrec,6916,https://t.me/bezrec/6916,"–í —Å–µ–≥–æ–¥–Ω—è—à–Ω–µ–º –≤—ã–ø—É—Å–∫–µ —Ä—É–±—Ä–∏–∫–∏ #—Ñ–∞—Ä–º–Ω–∞–π–º —Ä–µ—à–∏–ª–∏ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å, –∫–∞–∫–∏–µ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–µ –≤–∞–∫–∞–Ω—Å–∏–∏ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –ª–∏–¥–µ—Ä—ã —Ç–æ–ø-10 –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –≤–æ –≤–µ—Ä—Å–∏–∏ DSM Group. ¬´–†–∏–≥–ª–∞¬ª üîò–°—Ç–∞—Ä—à–∏–π —é—Ä–∏—Å–∫–æ–Ω—Å—É–ª—å—Ç (–ò–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω–∞—è —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å) –£—Å–ø–µ—à–Ω–æ–º—É –∫–∞–Ω–¥–∏–¥–∞—Ç—É –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –∑–∞–Ω–∏–º–∞—Ç—å—Å—è –ø—Ä–∞–≤–æ–≤—ã–º —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏–µ–º —Å–¥–µ–ª–æ–∫ (–∏—Ö —É –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–µ–º–∞–ª–æ), –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–µ–º —Å –†–æ—Å–ø–∞—Ç–µ–Ω—Ç–æ–º, —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–∏–µ–º —Ä–µ–∫–ª–∞–º–Ω–æ-–∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã—Ö –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤, –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ–º –≤ —Å—Ñ–µ—Ä–µ –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–π –ø—Ä–æ–¥–∞–∂–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –¥—Ä. –í–∑–∞–º–µ–Ω ‚Äì –≥–∏–±—Ä–∏–¥, —ç–∫—Å–∫–ª—é–∑–∏–≤–Ω—ã–µ —Å–∫–∏–¥–∫–∏ –Ω–∞ –ø–æ–∫—É–ø–∫–∏ –≤ —Å–µ—Ç–∏ –∏ –ø—Ä–æ–≥—Ä–∞–º–º–∞ –∑–∞—â–∏—Ç—ã –∑–¥–æ—Ä–æ–≤—å—è –ø–æ—Å–ª–µ –∏—Å–ø—ã—Ç–∞—Ç–µ–ª—å–Ω–æ–≥–æ —Å—Ä–æ–∫–∞. üîò–ú–µ–Ω–µ–¥–∂–µ—Ä –ø–æ –º–µ–¥–∏–∞-–∞–Ω–∞–ª–∏—Ç–∏–∫–µ –¢—Ä–µ–±—É—é—Ç –ø—Ä–æ–¥–≤–∏–Ω—É—Ç–æ–µ –≤–ª–∞–¥–µ–Ω–∏–µ Excel –¥–ª—è –æ–±—Ä–∞–±–æ—Ç–∫–∏ –±–æ–ª—å—à–∏—Ö –æ–±—ä—ë–º–æ–≤ –¥–∞–Ω–Ω—ã—Ö, —Ä–∞—Å—á—ë—Ç–æ–≤ –∏ –ø–æ—Å—Ç—Ä–æ–µ–Ω–∏—è –æ—Ç—á—ë—Ç–æ–≤, –ø–æ–Ω–∏–º–∞–Ω–∏–µ —Ä–µ–∫–ª–∞–º–Ω—ã—Ö –º–µ—Ç—Ä–∏–∫ –∏ –∑–Ω–∞–Ω–∏–µ –º–µ–¥–∏–∞—Ä—ã–Ω–∫–∞. –ò–∑ ¬´–ø–ª—é—à–µ–∫¬ª ‚Äî ¬´–ª–∏—á–Ω—ã–π¬ª –ø—Ä–æ–¥—É–∫—Ç –î–ú–° (—á—Ç–æ –±—ã —ç—Ç–æ –Ω–∏ –∑–Ω–∞—á–∏–ª–æ) –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –≥–∏–±—Ä–∏–¥–∞. ¬´–ê–ø—Ä–µ–ª—å¬ª üîò–ê—Ä—Ö–∏—Ç–µ–∫—Ç–æ—Ä-—á–µ—Ä—Ç–µ–∂–Ω–∏–∫ –ù–µ—Ç–∏–ø–∏—á–Ω–∞—è –¥–ª—è –æ—Ç—Ä–∞—Å–ª–∏ –≤–∞–∫–∞–Ω—Å–∏—è –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –ø–ª–∞–Ω–æ–≤ —ç—Ç–∞–∂–µ–π, —Ñ–∞—Å–∞–¥–æ–≤, —Ä–∞–∑—Ä–µ–∑–æ–≤ –∏ —É–∑–ª–æ–≤, —Å–æ–∑–¥–∞–Ω–∏–µ —Å–ø–µ—Ü–∏—Ñ–∏–∫–∞—Ü–∏–π –¥–ª—è —Å—Ç—Ä–æ–∏—Ç–µ–ª—å–Ω—ã—Ö –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤, –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –∏ –æ—Ç–¥–µ–ª–∫–∏, –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏—è —Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞–º –∏ –¥—Ä. –í–∑–∞–º–µ–Ω –æ–±–µ—â–∞—é—Ç –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω–æ–µ 2-—Ö —Ä–∞–∑–æ–≤–æ–µ –ø–∏—Ç–∞–Ω–∏–µ –∏ —Å–æ–≤–º–µ—Å—Ç–Ω—ã–µ –≤—ã–µ–∑–¥—ã –Ω–∞ –±–∞–∑—É –æ—Ç–¥—ã—Ö–∞ –Ω–∞ –ß–µ—Ä–Ω–æ–º–æ—Ä—Å–∫–æ–º –ø–æ–±–µ—Ä–µ–∂—å–µ. üîò–ú–µ–Ω–µ–¥–∂–µ—Ä –ø–æ –æ—Ç–∫—Ä—ã—Ç–∏—é –ö–∞–∫ –ø–æ–Ω—è—Ç–Ω–æ –∏–∑ –Ω–∞–∑–≤–∞–Ω–∏—è –≤–∞–∫–∞–Ω—Å–∏–∏, —É—Å–ø–µ—à–Ω–æ–º—É –∫–∞–Ω–¥–∏–¥–∞—Ç—É –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è —Ä–∞–±–æ—Ç—ã –ø–æ –æ—Ç–∫—Ä—ã—Ç–∏—é –∞–ø—Ç–µ–∫ —Å –º–æ–º–µ–Ω—Ç–∞ –ø—Ä–∏–µ–º–∞ –ø–æ–º–µ—â–µ–Ω–∏—è –¥–æ –¥–∞—Ç—ã —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–≥–æ –æ—Ç–∫—Ä—ã—Ç–∏—è. –ü–æ–º–∏–º–æ –ø—Ä–æ—á–µ–≥–æ, –Ω—É–∂–Ω–æ –±—É–¥–µ—Ç –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä–æ–≤–∞—Ç—å –ø–æ–¥–≥–æ—Ç–æ–≤–∫—É —Ç–æ—á–µ–∫ –∫ –≤—ã–µ–∑–¥–Ω—ã–º –ø—Ä–æ–≤–µ—Ä–∫–∞–º. –ü–æ —É—Å–ª–æ–≤–∏—è–º –∫–æ–Ω–∫—Ä–µ—Ç–∏–∫–∏ –Ω–µ—Ç ‚Äì —Å–ø–ª–æ—à—å —Ä–∞–∑–º—ã—Ç—ã–µ ¬´—É–≤–µ—Ä–µ–Ω–Ω–æ—Å—Ç—å –≤ –∑–∞–≤—Ç—Ä–∞—à–Ω–µ–º –¥–Ω–µ¬ª –∏ ¬´—Ä–∞–±–æ—Ç–∞¬ª –≤ —Å–∞–º–æ–π –∫—Ä—É–ø–Ω–æ–π –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ —Å—Ç—Ä–∞–Ω—ã. ¬´–ü–ª–∞–Ω–µ—Ç–∞ –∑–¥–æ—Ä–æ–≤—å—è¬ª –ú–µ–Ω–µ–¥–∂–µ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –±—Ä–µ–Ω–¥–∞ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª—è –£—Å–ø–µ—à–Ω–æ–º—É –∫–∞–Ω–¥–∏–¥–∞—Ç—É –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –æ—Ç—Å–ª–µ–∂–∏–≤–∞—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ä–µ–∫–ª–∞–º–Ω—ã—Ö –∫–∞–Ω–∞–ª–æ–≤, –ø–æ–≤—ã—à–∞—Ç—å —É–∑–Ω–∞–≤–∞–µ–º–æ—Å—Ç—å –±—Ä–µ–Ω–¥–∞ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª—è, —Å–æ–∑–¥–∞–≤–∞—Ç—å –∏ –≤–µ—Å—Ç–∏ —Å–æ—Ü—Å–µ—Ç–∏ –∫–æ–º–ø–∞–Ω–∏–∏ –∫–∞–∫ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª—è. –ï—Å—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –≥–∏–±—Ä–∏–¥–Ω–æ–≥–æ –≥—Ä–∞—Ñ–∏–∫–∞ —Ä–∞–±–æ—Ç—ã. –û–±–µ—â–∞—é—Ç –æ–ø–ª–∞—Ç—É –º–æ–±–∏–ª—å–Ω–æ–π —Å–≤—è–∑–∏ –∏ –Ω–∞—Å—ã—â–µ–Ω–Ω—É—é –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω—É—é –∂–∏–∑–Ω—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-12-10T05:33:44+00:00,@bezrec,6915,https://t.me/bezrec/6915,"–í—ã–ø—É—â–µ–Ω—ã –ø–µ—Ä–≤—ã–µ —Ç—Ä–∏ —Ç–µ—Å—Ç–æ–≤—ã–µ —Å–µ—Ä–∏–∏ –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω—ã. –ü–æ —Å–ª–æ–≤–∞–º –≥–ª–∞–≤—ã —Ü–µ–Ω—Ç—Ä–∞ –∏–º. –ì–∞–º–∞–ª–µ–∏ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –ì–∏–Ω—Ü–±—É—Ä–≥–∞, ¬´—Ñ–∞–±—Ä–∏–∫–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω—ã –≤ –∏–Ω—Å—Ç–∏—Ç—É—Ç–µ –ì–∞–º–∞–ª–µ–∏ –Ω–µ —Ç–æ–ª—å–∫–æ –ø–æ—Å—Ç—Ä–æ–µ–Ω–∞, –Ω–æ –∏ –ø–æ–ª–Ω–æ—Å—Ç—å—é –æ—Å–Ω–∞—â–µ–Ω–∞ –∏ –≤—ã–ø—É—Å—Ç–∏–ª–∞ –ø–µ—Ä–≤—ã–µ —Ç—Ä–∏ –≤–∞–ª–∏–¥–∞—Ü–∏–æ–Ω–Ω—ã–µ —Å–µ—Ä–∏–∏¬ª. –°–∞–º–æ–µ –≥–ª–∞–≤–Ω–æ–µ ‚Äî –≤ –Ω–∞—à–µ–º –≤–µ–¥—É—â–µ–º –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–º —Ü–µ–Ω—Ç—Ä–µ –ì–µ—Ä—Ü–µ–Ω–∞ –ø–æ–¥ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–º –∞–∫–∞–¥–µ–º–∏–∫–∞ –ö–∞–ø—Ä–∏–Ω–∞ –ø–æ–ª—É—á–µ–Ω –≤–µ—Å—å —Ä–∞–∑—Ä–µ—à–∏—Ç–µ–ª—å–Ω—ã–π –ø–∞–∫–µ—Ç –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏, –Ω–∞—á–∏–Ω–∞—è –æ—Ç –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –∏ –∑–∞–∫–∞–Ω—á–∏–≤–∞—è –≤—ã–ø—É—Å–∫–æ–º –º–†–ù–ö –∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º —É –±–æ–ª—å–Ω—ã—Ö –ª—é–¥–µ–π, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ì–∏–Ω—Ü–±—É—Ä–≥. –†–∞–Ω–µ–µ –≥–ª–∞–≤–Ω—ã–π –æ–Ω–∫–æ–ª–æ–≥ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ê–Ω–¥—Ä–µ–π –ö–∞–ø—Ä–∏–Ω –ø–æ—è—Å–Ω—è–ª, —á—Ç–æ –Ω–∞ –Ω–∞—á–∞–ª—å–Ω–æ–º —ç—Ç–∞–ø–µ –ù–µ–æ–æ–Ω–∫–æ–≤–∞–∫ –º–æ–∂–µ—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è —É –≤–∑—Ä–æ—Å–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –Ω–µ–æ–ø–µ—Ä–∞–±–µ–ª—å–Ω–æ–π –∏–ª–∏ –º–µ—Ç–∞—Å—Ç–∞—Ç–∏—á–µ—Å–∫–æ–π –º–µ–ª–∞–Ω–æ–º–æ–π –∫–æ–∂–∏ –≤ –∫–æ–º–±–∏–Ω–∞—Ü–∏–∏ —Å –∏–º–º—É–Ω–æ—Ç–µ—Ä–∞–ø–∏–µ–π. –ü–æ—Ä—è–¥–æ–∫ –ø–æ–ª—É—á–µ–Ω–∏—è –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω—ã –±—É–¥–µ—Ç –ø–æ–¥—Ä–æ–±–Ω–æ —Ä–∞–∑—ä—è—Å–Ω–µ–Ω –ø–æ–∑–∂–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""vaccine, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The first three test series of the oncok vaccine have been released. According to Alexander Ginzburg, head of the Gamaleya Center, 'the mRNA vaccine production plant at the Gamaleya Institute is not only built but fully equipped and has produced the first three validation series.' The most important thing is that in our leading oncology center Herzhen under the leadership of Academician Kaprin, all regulatory documents for using the technology have been obtained, from diagnosis to producing mRNA and applying it to patients. Earlier, the main oncologist of the Ministry of Health Andrei Kaprin explained that at the initial stage, NeoOncoV can be used in adults with unresectable or metastatic melanoma skin in combination with immunotherapy. The order for obtaining personalized mRNA vaccine will be detailed later.""
}"
2025-12-10T16:36:35+00:00,@medpharm,13967,https://t.me/medpharm/13967,"ü¶æ –í–Ω–µ –∑–æ–Ω—ã –¥–æ—Å—Ç—É–ø–∞. –í –ø–æ—á—Ç–∏ –ø–æ–ª—É—Ç–æ—Ä–∞ –¥–µ—Å—è—Ç–∫–∞—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤ –æ–±—â–µ–µ —á–∏—Å–ª–æ –ø—Ä–æ—à–µ–¥—à–∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏—é –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –∏–Ω—Å—É–ª—å—Ç–æ–º –Ω–µ –ø—Ä–µ–≤—ã—à–∞–ª–æ 2%. –í –æ—Ç–¥–µ–ª—å–Ω—ã—Ö —Å—É–±—ä–µ–∫—Ç–∞—Ö –†–§ —ç—Ç–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –±—ã–ª–∏ –Ω—É–ª–µ–≤—ã–º–∏. ü¶æ –í–æ–ø—Ä–æ—Å —Ä–µ–±—Ä–æ–º. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª –ø—Ä–∏–∫–∞–∑ –æ –ø–æ—Ä—è–¥–∫–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π. –û—Å—Ç–∞—é—Ç—Å—è –ª–∏ —É –≤–∞—Å –∏–ª–∏ –≤–∞—à–∏—Ö –∫–æ–ª–ª–µ–≥ –≤–æ–ø—Ä–æ—Å—ã –≤ —Å–≤—è–∑–∏ —Å —Ä–∞–±–æ—Ç–æ–π –≤ —Ä–∞–º–∫–∞—Ö –ö–†? ‚ù§Ô∏è –¶–∏—Ñ—Ä—ã –∏ —Å—Ä–æ–∫–∏. –§–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ —É—Å—Ç–∞–Ω–æ–≤–∏–ª–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ —É—Ä–æ–≤–Ω—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏. –ö–∞–∫ —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏—è –æ—Ç–Ω–µ—Å–ª–∞—Å—å –∫ –°—Ç—Ä–∞—Ç–µ–≥–∏–∏ —Ä–∞–∑–≤–∏—Ç–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –¥–æ 2030 –≥–æ–¥–∞, –≤—ã—è—Å–Ω–∏–ª ¬´–§–í¬ª. ‚ù§Ô∏è –î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–∞—è —ç–Ω–µ—Ä–≥–∏—è. –ü—Ä–æ–¥–∞–≤–∞—Ç—å —ç–Ω–µ—Ä–≥–µ—Ç–∏—á–µ—Å–∫–∏–µ –Ω–∞–ø–∏—Ç–∫–∏ —Å–ª–µ–¥—É–µ—Ç —Ç–æ–ª—å–∫–æ –≤ –∞–ø—Ç–µ–∫–∞—Ö, —Å—á–∏—Ç–∞–µ—Ç —á–ª–µ–Ω –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –†–§ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –°—É–ª—Ç–∞–Ω –•–∞–º–∑–∞–µ–≤. –¢–∞–∫–æ–≤–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–∞—è –ø—Ä–∞–∫—Ç–∏–∫–∞, –ø–æ—è—Å–Ω–∏–ª –æ–Ω.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,safety,regulation"",
  ""impact"": ""high"",
  ""english"": ""The data shows that in almost two-thirds of regions, the number of patients who have completed rehabilitation after a stroke was less than 2%. In some Russian subjects, these figures were zero. The Ministry of Health has approved an order on the application of clinical recommendations. Are there any questions regarding work within the Clinical Recommendations (CR) framework? The numbers and timelines show that Farmitalli set standards for technological independence. How did the pharmaceutical industry respond to the Strategy for the Development of Healthcare up to 2030, as reported by 'FV'? It is suggested that energy drinks should only be sold in pharmacies, according to member of the Committee of the State Duma of Russia on health protection Sultan Hamzaev.""
}"
2025-12-10T15:39:05+00:00,@medpharm,13966,https://t.me/medpharm/13966,–£—Ç–≤–µ—Ä–∂–¥–µ–Ω –ü–æ—Ä—è–¥–æ–∫ –≤–µ–¥–µ–Ω–∏—è –æ–Ω–ª–∞–π–Ω-—Ä–µ–µ—Å—Ç—Ä–∞ –∑–∞–∫–ª—é—á–µ–Ω–∏–π –æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ –º–µ–¥–≤—É–∑–æ–≤ –∏ –∫–æ–ª–ª–µ–¥–∂–µ–π —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º –ø–æ –∫–∞–¥—Ä–∞–º –∏ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—é –¥–ª—è –ø—Ä–∞–∫—Ç–∏–∫–∏ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤. –ü—Ä–∏–∫–∞–∑ –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qmgqn #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration"",
  ""impact"": ""high"",
  ""english"": ""The Order on the online registration of medical institutions and colleges' compliance with staffing and equipment requirements for student practice has been approved. The order will take effect on March 1, 2026. More details: https://clck.ru/3Qmgqn #MedVestnik #Education #Other""
}"
2025-12-10T15:19:03+00:00,@medpharm,13965,https://t.me/medpharm/13965,"–î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –°—É–ª—Ç–∞–Ω –•–∞–º–∑–∞–µ–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —É–≤–µ–ª–∏—á–∏—Ç—å –∞–ø—Ç–µ—á–Ω—ã–π –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –Ω–µ–æ–∂–∏–¥–∞–Ω–Ω–æ–π –ø–æ–∑–∏—Ü–∏–µ–π. –ü–æ –µ–≥–æ –º–Ω–µ–Ω–∏—é, –ø—Ä–æ–¥–∞–≤–∞—Ç—å —ç–Ω–µ—Ä–≥–µ—Ç–∏—á–µ—Å–∫–∏–µ –Ω–∞–ø–∏—Ç–∫–∏ –Ω—É–∂–Ω–æ –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –≤ –∞–ø—Ç–µ–∫–∞—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmfuQ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Deputy of the Russian State Duma Sultan Hamzaev proposed to increase the pharmacy assortment with an unexpected product - energy drinks. According to his opinion, these products should be sold exclusively in pharmacies. More details: https://clck.ru/3QmfuQ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞""
}"
2025-12-10T14:48:03+00:00,@medpharm,13964,https://t.me/medpharm/13964,–°–±–µ—Ä –≤–Ω–µ–¥—Ä—è–µ—Ç –ò–ò –≤ —Ñ–∞—Ä–º—Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É. –ù–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ø–æ–º–æ–≥—É—Ç –∏—Å–∫–ª—é—á–∏—Ç—å —Ç—É–ø–∏–∫–æ–≤—ã–µ —ç—Ç–∞–ø—ã –∏ —É—Å–∫–æ—Ä–∏—Ç—å —Å–æ–∑–¥–∞–Ω–∏–µ —Ç–µ—Ä–∞–ø–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmeJy #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-10T14:48:03+00:00,@medpharm,13963,https://t.me/medpharm/13963,–û–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–æ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–µ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ ¬´–û–ø—É—Ö–æ–ª–∏ –∫–æ—Å—Ç–µ–π –∏ –º—è–≥–∫–∏—Ö —Ç–∫–∞–Ω–µ–π¬ª ‚Äî –¥–≤—É—Ö—Ç–æ–º–Ω–∏–∫ –∞–∫–∞–¥–µ–º–∏–∫–∞ –†–ê–ù –ú–∞–º–µ–¥–∞ –ê–ª–∏–µ–≤–∞. –ò–∑–¥–∞–Ω–∏–µ –æ–±–æ–±—â–∞–µ—Ç –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è –æ–Ω–∫–æ–æ—Ä—Ç–æ–ø–µ–¥–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmeJs #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û–Ω–∫–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-12-10T14:02:06+00:00,@medpharm,13962,https://t.me/medpharm/13962,"Pfizer –∑–∞–ø–ª–∞—Ç–∏—Ç 2,1 –º–ª—Ä–¥ –¥–æ–ª–ª. –∑–∞ –∫–∏—Ç–∞–π—Å–∫–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è. –≠—Ç–æ –≤—Ç–æ—Ä–∞—è –∫—Ä—É–ø–Ω–∞—è —Å–¥–µ–ª–∫–∞ —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç–∞ —Å —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ö–ù–† –∑–∞ 2025 –≥–æ–¥. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmbfQ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-12-10T12:25:05+00:00,@medpharm,13961,https://t.me/medpharm/13961,"–°—É–¥ –≤ –ò—Ä–∫—É—Ç—Å–∫–µ –ø—Ä–∏–∑–Ω–∞–ª –≤–∏–Ω–æ–≤–Ω—ã–º–∏ —á–µ—Ç—ã—Ä–µ—Ö —Ñ–∏–≥—É—Ä–∞–Ω—Ç–æ–≤ –¥–µ–ª–∞ –æ —Ö–∏—â–µ–Ω–∏–∏ –±–æ–ª–µ–µ 22 –º–ª–Ω —Ä—É–±–ª–µ–π –ø—Ä–∏ –∑–∞–∫—É–ø–∫–µ –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –æ–Ω–∫–æ–¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∞. –ò–º –Ω–∞–∑–Ω–∞—á–µ–Ω—ã —Å—Ä–æ–∫–∏ –æ—Ç 3,5 –¥–æ 4 –ª–µ—Ç –∫–æ–ª–æ–Ω–∏–∏ –∏ –∫—Ä—É–ø–Ω—ã–µ —à—Ç—Ä–∞—Ñ—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmWr4 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-12-10T12:10:06+00:00,@medpharm,13960,https://t.me/medpharm/13960,"–ö–∞–∂–¥–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –æ—Ç–Ω–µ—Å–µ–Ω–∞ –∫ –æ–¥–Ω–æ–π –∏–∑ —à–µ—Å—Ç–∏ –∫–∞—Ç–µ–≥–æ—Ä–∏–π ‚Äì –æ—Ç ¬´—á—Ä–µ–∑–≤—ã—á–∞–π–Ω–æ –≤—ã—Å–æ–∫–æ–≥–æ¬ª –¥–æ ¬´–Ω–∏–∑–∫–æ–≥–æ¬ª —Ä–∏—Å–∫–∞. –û—Ç —ç—Ç–æ–≥–æ –∑–∞–≤–∏—Å–∏—Ç —á–∞—Å—Ç–æ—Ç–∞ –∏ –∏–Ω—Ç–µ–Ω—Å–∏–≤–Ω–æ—Å—Ç—å –ø—Ä–æ–≤–µ—Ä–æ–∫ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞. –ö–∞–∫ –æ–ø—Ä–µ–¥–µ–ª–∏—Ç—å, –∫ –∫–∞–∫–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ —Ä–∏—Å–∫–∞ –æ—Ç–Ω–æ—Å–∏—Ç—Å—è —Ñ–∞—Ä–º–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è, –≤ —Ç–æ–º —á–∏—Å–ª–µ –∏ –∞–ø—Ç–µ–∫–∞? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmUAC #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation"",
  ""impact"": ""high"",
  ""english"": ""To determine the risk category for a pharmaceutical organization, including pharmacies, one should refer to the categories defined by the Russian Health Supervision. This categorization affects the frequency and intensity of inspections by the Russian Health Supervision.""
}"
2025-12-10T11:45:04+00:00,@medpharm,13959,https://t.me/medpharm/13959,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª –ø–æ—Ä—è–¥–æ–∫ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π. –î–æ–∫—É–º–µ–Ω—Ç —Å–æ—Å—Ç–æ–∏—Ç –∏–∑ –≤–æ—Å—å–º–∏ –ø—É–Ω–∫—Ç–æ–≤. –í –ø—Ä–∏–∫–∞–∑–µ —É—Ç–æ—á–Ω–µ–Ω–æ, –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã –ª–∏ –∫–ª–∏–Ω—Ä–µ–∫–∏ –∏ —á—Ç–æ –¥–µ–ª–∞—Ç—å –ø—Ä–∏ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –æ–∫–∞–∑–∞—Ç—å –ø–æ–º–æ—â—å –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –Ω–∏–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmSQn #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""high"",
  ""english"": ""The Russian Ministry of Health has approved the application guidelines for clinical recommendations. The document consists of eight points and clarifies whether these recommendations are mandatory and what to do if they cannot be implemented.""
}"
2025-12-10T11:21:03+00:00,@medpharm,13958,https://t.me/medpharm/13958,"–ú–µ–Ω—å—à–µ –≤—Å–µ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â—å—é –¥–æ–≤–æ–ª—å–Ω—ã –∂–∏—Ç–µ–ª–∏ –¥–≤—É—Ö —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤, —Å–æ–æ–±—â–∏–ª–∏ –≤ –∞–ø–ø–∞—Ä–∞—Ç–µ —É–ø–æ–ª–Ω–æ–º–æ—á–µ–Ω–Ω–æ–≥–æ –ø–æ –ø—Ä–∞–≤–∞–º —á–µ–ª–æ–≤–µ–∫–∞. –ì–ª–∞–≤–Ω—ã–º–∏ –ø—Ä–∏—á–∏–Ω–∞–º–∏ —ç—Ç–æ–≥–æ —Å—Ç–∞–ª–∏ –æ—Å—Ç—Ä—ã–π –¥–µ—Ñ–∏—Ü–∏—Ç –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∏ –ø—Ä–æ–±–ª–µ–º—ã —Å –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º –ª—å–≥–æ—Ç–Ω—ã–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmQj7 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Residents of two Russian regions are least satisfied with medical care. The main reasons for this were a severe shortage of healthcare workers and problems with ensuring subsidized medications. More details: https://clck.ru/3QmQj7 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è""
}"
2025-12-10T10:39:04+00:00,@medpharm,13957,https://t.me/medpharm/13957,FDA –æ–¥–æ–±—Ä–∏–ª–æ –ø–µ—Ä–≤—ã–π –ò–ò-–∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç –¥–ª—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–æ–≤—ã–π –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç –±—É–¥–µ—Ç –ø–æ–º–æ–≥–∞—Ç—å –æ—Ü–µ–Ω–∏–≤–∞—Ç—å –±–∏–æ–ø—Å–∏–∏ –ø–µ—á–µ–Ω–∏ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏—è—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmMca #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-10T10:19:05+00:00,@medpharm,13956,https://t.me/medpharm/13956,–í —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö —Å–∏—Å—Ç–µ–º–∞—Ö –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –≤—ã—Å–æ–∫–∞—è –¥–∏—Ñ—Ñ–µ—Ä–µ–Ω—Ü–∏–∞—Ü–∏—è —Å –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏—è —Ü–∏—Ñ—Ä–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π. –°—Ç–∏–º—É–ª–∏—Ä–æ–≤–∞—Ç—å –ø—Ä–æ—Ü–µ—Å—Å –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —Å –ø–æ–º–æ—â—å—é –æ–±—ä–µ–∫—Ç–∏–≤–Ω–æ–≥–æ —Ä–µ–π—Ç–∏–Ω–≥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmLEV #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-12-10T09:39:03+00:00,@medpharm,13955,https://t.me/medpharm/13955,"–û–º–±—É–¥—Å–º–µ–Ω —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –æ –∂–∞–ª–æ–±–∞—Ö –Ω–∞ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –ª—å–≥–æ—Ç–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –†–æ—Å—Å–∏–∏. –ü–æ —Å–ª–æ–≤–∞–º –¢–∞—Ç—å—è–Ω—ã –ú–æ—Å–∫–∞–ª—å–∫–æ–≤–æ–π, –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –æ–±—Ä–∞—â–µ–Ω–∏–π —Å–Ω–∏–∂–∞–µ—Ç—Å—è. –û–¥–Ω–∞–∫–æ –æ–¥–Ω–æ–π –∏–∑ –≥–ª–∞–≤–Ω—ã—Ö –ø—Ä–æ–±–ª–µ–º –æ—Å—Ç–∞–µ—Ç—Å—è –Ω–µ—Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω–∞—è –∑–∞–∫—É–ø–∫–∞ —Ä–µ–≥–∏–æ–Ω–∞–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmHPx #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The Ombudsman reported on complaints about the accessibility of subsidized medications in Russia. Ms. Tatyana Moskal'kova stated that the number of complaints is decreasing. However, one of the main problems remains the delayed procurement by regions.""
}"
2025-12-10T09:22:03+00:00,@medpharm,13954,https://t.me/medpharm/13954,–°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–º–∏—Ç–µ—Ç –†–æ—Å—Å–∏–∏ –Ω–∞—á–∞–ª –ø—Ä–æ–≤–µ—Ä–∫—É –ø–æ –∂–∞–ª–æ–±–µ –≤—Ä–∞—á–µ–π –±–æ–ª—å–Ω–∏—Ü—ã –≤ –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –Ω–∞ –Ω–∏–∑–∫–∏–µ –∑–∞—Ä–ø–ª–∞—Ç—ã –∏ –ø–ª–æ—Ö–∏–µ —É—Å–ª–æ–≤–∏—è —Ç—Ä—É–¥–∞. –ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–µ–≥–∏–æ–Ω–∞ —Å–æ–∑–¥–∞–ª —Ä–∞–±–æ—á—É—é –≥—Ä—É–ø–ø—É –¥–ª—è —Ä–∞–∑–±–æ—Ä–∞ —Å–∏—Ç—É–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmG4K #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-12-10T08:30:03+00:00,@medpharm,13953,https://t.me/medpharm/13953,"–ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª –°—Ç—Ä–∞—Ç–µ–≥–∏—é —Ä–∞–∑–≤–∏—Ç–∏—è –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –¥–æ 2030 –≥–æ–¥–∞. –í –¥–æ–∫—É–º–µ–Ω—Ç–µ —É–¥–µ–ª–µ–Ω–æ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤, –∞ —Ç–∞–∫–∂–µ –∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É. –£—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ —É—Ä–æ–≤–Ω—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏. –ö–∞–∫ —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏—è –æ—Ç–Ω–µ—Å–ª–∞—Å—å –∫ —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏, –≤—ã—è—Å–Ω–∏–ª ¬´–§–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmBo3 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, production, technology independence"",
  ""impact"": ""high"",
  ""english"": ""The President of Russia approved the Strategy for the Development of Domestic Healthcare until 2030. The document pays significant attention to the development and production of medicines, as well as technological self-sufficiency levels. How did the pharmaceutical industry respond to the strategy? 'FV' investigated. More details: https://clck.ru/3QmBo3 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ""
}"
2025-12-10T08:24:04+00:00,@medpharm,13952,https://t.me/medpharm/13952,–¶–µ–Ω—Ç—Ä —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –∏ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ —Å–æ–±—Ä–∞–ª –¥–∞–Ω–Ω—ã–µ –æ —Ä–µ–≥–∏–æ–Ω–∞—Ö —Å —Å–∞–º—ã–º–∏ –ø–ª–æ—Ö–∏–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –æ—Å—Ç—Ä—ã–º–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏ –º–æ–∑–≥–æ–≤–æ–≥–æ –∫—Ä–æ–≤–æ–æ–±—Ä–∞—â–µ–Ω–∏—è. –ü–æ –∏—Ç–æ–≥–∞–º –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ –ø–æ—á—Ç–∏ –≤ –ø–æ–ª—É—Ç–æ—Ä–∞ –¥–µ—Å—è—Ç–∫–∞—Ö —Å—É–±—ä–µ–∫—Ç–æ–≤ –æ–±—â–µ–µ —á–∏—Å–ª–æ –ø–æ–ª—É—á–∏–≤—à–∏—Ö —Ç–∞–∫—É—é –ø–æ–º–æ—â—å –Ω–µ –ø—Ä–µ–≤—ã—à–∞–ª–æ 2‚Äî3%. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QmBPR #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The Center for Expert Evaluation and Quality Control of Medical Assistance in the Ministry of Health of Russia gathered data on regions with the worst indicators of accessibility to medical rehabilitation patients with acute brain circulation disorders. According to last year's results, in over a dozen subjects, the total number of those receiving such assistance did not exceed 2-3%. More details: https://clck.ru/3QmBPR #MedVestnik #Healthcare #Neurology #Therapy""
}"
2025-12-10T07:57:03+00:00,@medpharm,13951,https://t.me/medpharm/13951,"–í –ú–æ—Å–∫–≤–µ –∏ –û—Ä–µ–Ω–±—É—Ä–≥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –∑–∞–¥–µ—Ä–∂–∞–ª–∏ –≥—Ä—É–ø–ø—É —Ç–æ—Ä–≥–æ–≤—Ü–µ–≤ –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –ò–∑—ä—è—Ç–æ –±–æ–ª–µ–µ 600 —É–ø–∞–∫–æ–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤, –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω—ã–π —É—â–µ—Ä–± —Å–æ—Å—Ç–∞–≤–∏–ª –±–æ–ª–µ–µ 200 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qm99g #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, shortage"",
  ""impact"": ""high"",
  ""english"": ""In Moscow and Orenburg Oblast, authorities arrested a group of sellers of unregistered medicines. Over 600 packages of medicine were seized, with an estimated loss of over 200 million rubles.""
}"
2025-12-10T07:38:05+00:00,@medpharm,13950,https://t.me/medpharm/13950,"–ü–∞—Ü–∏–µ–Ω—Ç –≤ –°–®–ê –ø–æ–≥–∏–± –æ—Ç –±–µ—à–µ–Ω—Å—Ç–≤–∞, –∑–∞—Ä–∞–∑–∏–≤—à–∏—Å—å –æ—Ç –¥–æ–Ω–æ—Ä–∞ –ø–æ—á–∫–∏. –ü–æ–ª—É—á–∏–≤—à–∏—Ö —Ä–æ–≥–æ–≤–∏—Ü—ã —Ä–µ—Ü–∏–ø–∏–µ–Ω—Ç–æ–≤ —É–¥–∞–ª–æ—Å—å —Å–ø–∞—Å—Ç–∏, —ç–∫—Å—Ç—Ä–µ–Ω–Ω–æ —É–¥–∞–ª–∏–≤ –ø–µ—Ä–µ—Å–∞–∂–µ–Ω–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qm7hw #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏","{""skip"": true}"
2025-12-10T18:23:20+00:00,@rus_med,7664,https://t.me/rus_med/7664,"ü¶†üò∑ –í—Å–µ –≥–æ–≤–æ—Ä—è—Ç –æ –≥—Ä–∏–ø–ø–µ, –Ω–∞–∫—Ä—ã–≤—à–µ–º –ú–æ—Å–∫–≤—É –∏ —Ä–µ–≥–∏–æ–Ω—ã, –∞ –≤ –ú–ì–£ —Å–≤–æ—è –±–µ–¥–∞‚Ä¶ –û–¥–∏–Ω –∏–∑ –∫–æ—Ä–ø—É—Å–æ–≤ –ú–ì–£ –Ω–∞ –õ–µ–Ω–∏–Ω—Å–∫–∏—Ö –≥–æ—Ä–∞—Ö –∑–∞–∫—Ä—ã–≤–∞—é—Ç –Ω–∞ –∫–∞—Ä–∞–Ω—Ç–∏–Ω ‚Äî –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–∞ –≤—Å–ø—ã—à–∫–∞ –∫–æ—Ä–∏.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""epidemic, vaccine"",
  ""impact"": ""high"",
  ""english"": ""There is a flu outbreak in Moscow and surrounding regions, as well as an epidemic of measles at one of the campuses of MGU on Lenin Hills. The campus has been closed for quarantine.""
}"
2025-12-10T14:31:27+00:00,@gxpnews,7579,https://t.me/gxpnews/7579,"üî¥ –ú–µ—Ö–∞–Ω–∏–∑–º ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –Ω–∞—á–∞–ª —Ä–∞–±–æ—Ç–∞—Ç—å, –æ–¥–Ω–∞–∫–æ –Ω–µ –≤—Å–µ –µ–≥–æ —Å–æ—Å—Ç–∞–≤–ª—è—é—â–∏–µ –≥–æ—Ç–æ–≤—ã. –ù–∞–ø—Ä–∏–º–µ—Ä, —Å–∏—Å—Ç–µ–º–∞ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏, –∫–æ—Ç–æ—Ä–∞—è —Å–µ–π—á–∞—Å –≤–Ω–µ–¥—Ä—è–µ—Ç—Å—è –∏ –¥–æ–ª–∂–Ω–∞ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—Ç—å –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—é –ø—Ä–æ–¥—É–∫—Ç–∞ –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞, –≤–∫–ª—é—á–∞—è –≤—ã–ø—É—Å–∫ –ê–§–°. ‚û°Ô∏è –¢–∞–∫–∂–µ –¥–ª—è —Ä–∞–±–æ—Ç—ã –º–µ—Ö–∞–Ω–∏–∑–º–∞ –≤–∞–∂–Ω–∞ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—è –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –≤—Å–ø–æ–º–æ–≥–∞—Ç–µ–ª—å–Ω—ã—Ö –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤, –±–µ–∑ –∫–æ—Ç–æ—Ä—ã—Ö –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü–æ—ç—Ç–æ–º—É —Å–∏—Å—Ç–µ–º–∞ –¥–æ–ª–∂–Ω–∞ –∑–∞—Ä–∞–±–æ—Ç–∞—Ç—å. –í–æ–ø—Ä–æ—Å –ª–∏—à—å –≤ —Ç–æ–º, –Ω–∞ –∫–∞–∫–æ–º —ç—Ç–∞–ø–µ –º—ã –Ω–∞—Ö–æ–¥–∏–º—Å—è —Å–µ–≥–æ–¥–Ω—è. üì¢ –û–± —ç—Ç–æ–º ‚Äî –∫–æ–ª–æ–Ω–∫–∞ –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª –ï–≤–≥–µ–Ω–∏–∏ –®–∞–ø–∏—Ä–æ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""The mechanism of 'second unnecessary' is starting to work, but not all its components are ready yet. For example, the tracking system that is currently being implemented and should confirm the full lifecycle localization of products, including API production. Also, for the mechanism's operation, it is important to have localized quality auxiliary components without which the production of drugs cannot be carried out. Therefore, the system must work. The question is at what stage we are today.""
}"
2025-12-10T12:39:45+00:00,@gxpnews,7578,https://t.me/gxpnews/7578,[–§–∞—Ä–º—Ç–µ—Ö] –°–±–µ—Ä —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç –ø–ª–∞—Ç—Ñ–æ—Ä–º—É –¥–ª—è –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏ –ò–ò –≤ —Ñ–∞—Ä–º—Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É.,"{""skip"": true}"
2025-12-10T10:22:35+00:00,@gxpnews,7577,https://t.me/gxpnews/7577,[–§–∞—Ä–º—Ç–µ—Ö] –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä –æ–¥–æ–±—Ä–∏–ª –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ –¥–ª—è —É—Å–∫–æ—Ä–µ–Ω–∏—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –ø–µ—á–µ–Ω–∏.,"{""skip"": true}"
2025-12-10T08:39:19+00:00,@gxpnews,7576,https://t.me/gxpnews/7576,[–ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞] –í –†–°–ü–ü –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π –ø—Ä–æ–µ–∫—Ç –ø–æ –±–æ—Ä—å–±–µ —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –æ–±—Å—Ç—Ä—É–∫—Ç–∏–≤–Ω–æ–π –±–æ–ª–µ–∑–Ω—å—é –ª–µ–≥–∫–∏—Ö.,"{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""clinical_trial, regulation"",
  ""impact"": ""high"",
  ""english"": ""The Russian Federation Chamber of Commerce and Industry (RSPP) proposed to develop a federal project aimed at combating chronic obstructive pulmonary disease.""
}"
2025-12-10T06:02:01+00:00,@gxpnews,7575,https://t.me/gxpnews/7575,[–ë–∏–æ—Ç–µ—Ö] –§–∞–±—Ä–∏–∫–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –º–†–ù–ö-–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¶–µ–Ω—Ç—Ä–∞ –ì–∞–º–∞–ª–µ–∏ –≤—ã–ø—É—Å—Ç–∏–ª–∞ —Ç–µ—Å—Ç–æ–≤—ã–µ —Å–µ—Ä–∏–∏ –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç —Ä–∞–∫–∞.,"{
  ""skip"": true
}"
2025-12-10T03:51:01+00:00,@gxpnews,7574,https://t.me/gxpnews/7574,[–†–∏—Ç–µ–π–ª] –ù–∞–ª–æ–≥–æ–≤–∞—è —Ä–µ—Ñ–æ—Ä–º–∞ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ –∑–∞–∫—Ä—ã—Ç–∏—é –æ–∫–æ–ª–æ 2 —Ç—ã—Å. –∞–ø—Ç–µ–∫ –≤ –º–∞–ª—ã—Ö –≥–æ—Ä–æ–¥–∞—Ö –∏ —Å–µ–ª–∞—Ö.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A tax reform may lead to the closure of around 2,000 pharmacies in small towns and villages, impacting supply chain and market access for medicines.""
}"
2025-12-10T01:54:01+00:00,@gxpnews,7573,https://t.me/gxpnews/7573,[–†–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ] –ì–æ—Å–¥—É–º–∞ –ø—Ä–æ–¥–ª–∏–ª–∞ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –≤–≤–æ–∑ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö —É–ø–∞–∫–æ–≤–∫–∞—Ö –¥–æ –∫–æ–Ω—Ü–∞ 2027 –≥–æ–¥–∞.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export"",
  ""impact"": ""high"",
  ""english"": ""The State Duma extended the import permit for foreign-packaged medicines until December 31, 2027.""
}"
2025-12-10T15:21:07+00:00,@pharmvestnik,8362,https://t.me/pharmvestnik/8362,"–î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –°—É–ª—Ç–∞–Ω –•–∞–º–∑–∞–µ–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —É–≤–µ–ª–∏—á–∏—Ç—å –∞–ø—Ç–µ—á–Ω—ã–π –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –Ω–µ–æ–∂–∏–¥–∞–Ω–Ω–æ–π –ø–æ–∑–∏—Ü–∏–µ–π. –ü–æ –µ–≥–æ –º–Ω–µ–Ω–∏—é, –ø—Ä–æ–¥–∞–≤–∞—Ç—å —ç–Ω–µ—Ä–≥–µ—Ç–∏—á–µ—Å–∫–∏–µ –Ω–∞–ø–∏—Ç–∫–∏ –Ω—É–∂–Ω–æ –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –≤ –∞–ø—Ç–µ–∫–∞—Ö. #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""demand,safety"",
  ""impact"": ""high"",
  ""english"": ""Deputy of the Russian State Duma, Sultan Hamzaev, proposed increasing the pharmacy inventory with an unexpected product - energy drinks. According to his opinion, these beverages should be sold exclusively in pharmacies.""
}"
2025-12-10T14:48:50+00:00,@pharmvestnik,8361,https://t.me/pharmvestnik/8361,–°–±–µ—Ä –≤–Ω–µ–¥—Ä—è–µ—Ç –ò–ò –≤ —Ñ–∞—Ä–º—Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É. –ù–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ø–æ–º–æ–≥—É—Ç –∏—Å–∫–ª—é—á–∏—Ç—å —Ç—É–ø–∏–∫–æ–≤—ã–µ —ç—Ç–∞–ø—ã –∏ —É—Å–∫–æ—Ä–∏—Ç—å —Å–æ–∑–¥–∞–Ω–∏–µ —Ç–µ—Ä–∞–ø–∏–∏. #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-10T14:04:51+00:00,@pharmvestnik,8360,https://t.me/pharmvestnik/8360,"Pfizer –∑–∞–ø–ª–∞—Ç–∏—Ç 2,1 –º–ª—Ä–¥ –¥–æ–ª–ª. –∑–∞ –∫–∏—Ç–∞–π—Å–∫–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è. –≠—Ç–æ –≤—Ç–æ—Ä–∞—è –∫—Ä—É–ø–Ω–∞—è —Å–¥–µ–ª–∫–∞ —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç–∞ —Å —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ö–ù–† –∑–∞ 2025 –≥–æ–¥. #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-12-10T12:07:13+00:00,@pharmvestnik,8358,https://t.me/pharmvestnik/8358,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª –ø–æ—Ä—è–¥–æ–∫ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π. –î–æ–∫—É–º–µ–Ω—Ç —Å–æ—Å—Ç–æ–∏—Ç –∏–∑ –≤–æ—Å—å–º–∏ –ø—É–Ω–∫—Ç–æ–≤. –í –ø—Ä–∏–∫–∞–∑–µ —É—Ç–æ—á–Ω–µ–Ω–æ, –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã –ª–∏ –∫–ª–∏–Ω—Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –∏ —á—Ç–æ –¥–µ–ª–∞—Ç—å –ø—Ä–∏ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –æ–∫–∞–∑–∞—Ç—å –ø–æ–º–æ—â—å –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –Ω–∏–º–∏. #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Ministry of Health of Russia has approved the order on applying clinical recommendations. The document consists of eight points. In the decree, it is clarified whether clinical recommendations are mandatory and what to do in case they cannot be provided.""
}"
2025-12-10T10:46:36+00:00,@pharmvestnik,8357,https://t.me/pharmvestnik/8357,FDA –æ–¥–æ–±—Ä–∏–ª–æ –ø–µ—Ä–≤—ã–π –ò–ò-–∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç –¥–ª—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–æ–≤—ã–π –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç –±—É–¥–µ—Ç –ø–æ–º–æ–≥–∞—Ç—å –æ—Ü–µ–Ω–∏–≤–∞—Ç—å –±–∏–æ–ø—Å–∏–∏ –ø–µ—á–µ–Ω–∏ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏—è—Ö. #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-10T08:09:01+00:00,@pharmvestnik,8354,https://t.me/pharmvestnik/8354,"–í –ú–æ—Å–∫–≤–µ –∏ –û—Ä–µ–Ω–±—É—Ä–≥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –∑–∞–¥–µ—Ä–∂–∞–ª–∏ –≥—Ä—É–ø–ø—É —Ç–æ—Ä–≥–æ–≤—Ü–µ–≤ –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –ò–∑—ä—è—Ç–æ –±–æ–ª–µ–µ 600 —É–ø–∞–∫–æ–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤, –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω—ã–π —É—â–µ—Ä–± —Å–æ—Å—Ç–∞–≤–∏–ª –±–æ–ª–µ–µ 200 –º–ª–Ω —Ä—É–±. #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""In Moscow and Orenburg Oblast, authorities arrested a group of sellers of unregistered medicines. Over 600 packages of medicine were seized, with an estimated loss of over 20 million rubles.""
}"
2025-12-10T07:44:01+00:00,@pharmvestnik,8353,https://t.me/pharmvestnik/8353,FDA –º–µ–Ω—è–µ—Ç —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –æ–¥–æ–±—Ä–µ–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤. –†–µ–≥—É–ª—è—Ç–æ—Ä —Ö–æ—á–µ—Ç —É—Å–∫–æ—Ä–∏—Ç—å –≤—ã—Ö–æ–¥ –∏–Ω–Ω–æ–≤–∞—Ü–∏–π –∏ —Å–Ω–∏–∑–∏—Ç—å –∑–∞—Ç—Ä–∞—Ç—ã —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–æ–≤. –ü–∞—Ä–∞–ª–ª–µ–ª—å–Ω–æ –≤—ã–¥–≤–∏–≥–∞—é—Ç—Å—è –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è —É–∂–µ—Å—Ç–æ—á–∏—Ç—å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –≤–∞–∫—Ü–∏–Ω. #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-10T09:22:21+00:00,@pharmnewskz,6583,https://t.me/pharmnewskz/6583,"–ê –≤–æ—Ç –∏ –æ–¥–Ω–∞ –∏–∑ –≤–æ–∑–º–æ–∂–Ω—ã—Ö –ø—Ä–∏—á–∏–Ω —É–¥–æ—Ä–æ–∂–∞–Ω–∏—è —Ñ—Ä—É–∫—Ç–æ–≤ –∏ –æ–≤–æ—â–µ–π –≤ —Å—Ç—Ä–∞–Ω–µ. –î–µ–ø—É—Ç–∞—Ç—Å–∫–∏–π –∑–∞–ø—Ä–æ—Å —Ñ—Ä–∞–∫—Ü–∏–∏ ¬´–ê–∫–∂–æ–ª¬ª –æ –ø—Ä–æ–±–ª–µ–º–∞—Ö –Ω–∞ –≥—Ä–∞–Ω–∏—Ü–µ –ü—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª–∏, —Ä–∞–±–æ—Ç–∞—é—â–∏–µ —Å –∏–º–ø–æ—Ä—Ç–æ–º —Ñ—Ä—É–∫—Ç–æ–≤ –∏ –æ–≤–æ—â–µ–π —á–µ—Ä–µ–∑ –ë–∞—Ö—Ç—ã –∏ –ß—ë—Ä–Ω—É—é —Ä–µ—á–∫—É, –∂–∞–ª—É—é—Ç—Å—è –Ω–∞ —Å–µ—Ä—å—ë–∑–Ω—ã–µ –∑–∞–¥–µ—Ä–∂–∫–∏ –∏ –≤—ã—Å–æ–∫–∏–µ —Ä–∞—Å—Ö–æ–¥—ã. –ü–æ—Å–ª–µ –ø—Ä–∏–∫–∞–∑–∞ ‚Ññ70 –†–ì–ü ¬´–§–∏—Ç–æ—Å–∞–Ω–∏—Ç–∞—Ä–∏—è¬ª —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ —Ç—Ä–µ–±—É—é—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—É—é –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—É—é —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—É –∫–∞–∂–¥–æ–π –º–∞—à–∏–Ω—ã, –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ –æ—Ç —Å–æ—Å—Ç–æ—è–Ω–∏—è —Ç–æ–≤–∞—Ä–∞, —á—Ç–æ –Ω–µ –∏–º–µ–µ—Ç –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã—Ö –æ—Å–Ω–æ–≤–∞–Ω–∏–π –∏ –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏—Ç –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–º –ø—Ä–∞–≤–∏–ª–∞–º. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –±–∏–∑–Ω–µ—Å –≤—ã–Ω—É–∂–¥–µ–Ω –ø–ª–∞—Ç–∏—Ç—å –¥–æ 300 000 —Ç–µ–Ω–≥–µ –∑–∞ –æ–¥–Ω—É –º–∞—à–∏–Ω—É, —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç –ø—Ä–æ—Å—Ç–∞–∏–≤–∞–µ—Ç, –Ω–∞—Ä—É—à–∞–µ—Ç—Å—è —Ç–µ–º–ø–µ—Ä–∞—Ç—É—Ä–Ω—ã–π —Ä–µ–∂–∏–º, –≤–æ–∑—Ä–∞—Å—Ç–∞–µ—Ç —Ä–∏—Å–∫ –ø–æ—Ä—á–∏ —Å–∫–æ—Ä–æ–ø–æ—Ä—Ç—è—â–µ–π—Å—è –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –ù–∞ –ø—É–Ω–∫—Ç–∞—Ö –ø—Ä–æ–ø—É—Å–∫–∞ —Ç–∞–∫–∂–µ –æ—Ç—Å—É—Ç—Å—Ç–≤—É—é—Ç —Ö–æ–ª–æ–¥–∏–ª—å–Ω—ã–µ –∫–∞–º–µ—Ä—ã –∏ –∫—Ä—ã—Ç—ã–µ –ø–ª–æ—â–∞–¥–∫–∏ –¥–ª—è –∫–æ–Ω—Ç—Ä–æ–ª—è. –§—Ä–∞–∫—Ü–∏—è ¬´–ê–∫–∂–æ–ª¬ª —Ç—Ä–µ–±—É–µ—Ç: - –ü—Ä–∏–≤–µ—Å—Ç–∏ –ø—Ä–∞–∫—Ç–∏–∫—É —Ñ–∏—Ç–æ—Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –Ω–æ—Ä–º–∞–º–∏ –ö–¢–° ‚Ññ318; - –î–∞—Ç—å –ø—Ä–∞–≤–æ–≤—É—é –æ—Ü–µ–Ω–∫—É –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–µ –∫–∞–∂–¥–æ–π –º–∞—à–∏–Ω—ã; - –ü–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å —Ç–∞—Ä–∏—Ñ—ã —ç–∫—Å–ø–µ—Ä—Ç–∏–∑ –∏ –æ–±–µ—Å–ø–µ—á–∏—Ç—å –ø—Ä–æ–∑—Ä–∞—á–Ω–æ–µ —Ü–µ–Ω–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ; - –ü—Ä–æ–≤–µ—Ä–∏—Ç—å —Å–∏—Ç—É–∞—Ü–∏—é –Ω–∞ –ø—É–Ω–∫—Ç–µ –ß—ë—Ä–Ω–∞—è —Ä–µ—á–∫–∞, –≤–∫–ª—é—á–∞—è –ø–æ—Ä—è–¥–æ–∫ –≤—ã–≥—Ä—É–∑–∫–∏ –∏ —Ö—Ä–∞–Ω–µ–Ω–∏—è —Ç–æ–≤–∞—Ä–æ–≤..","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""A parliamentary request from the 'Akjol' faction about border issues has led to delays and high costs for businesses importing fruits and vegetables through Bakhdat and Black River. The authorities require mandatory laboratory testing of every vehicle, regardless of its cargo condition, which is not legally justified and contradicts international rules. As a result, businesses are forced to pay up to 300,000 tenge per vehicle, causing transportation delays and increasing the risk of spoilage for perishable goods. The 'Akjol' faction demands: - Bring the phytosanitary control practice in line with KTS ‚Ññ318 norms; - Provide legal assessment of mandatory laboratory testing of every vehicle; - Review expert fees and ensure transparent pricing; - Check the situation at Black River crossing, including unloading and storage procedures.""
}"
2025-12-10T09:10:36+00:00,@pharmnewskz,6582,https://t.me/pharmnewskz/6582,"–ò–Ω—Ñ–ª—è—Ü–∏—è —Å—Ç–∞–ª–∞ –Ω–æ—Ä–º–æ–π –¥–ª—è –∫–∞–∑–∞—Ö—Å—Ç–∞–Ω—Ü–µ–≤ –ï–∂–µ–≥–æ–¥–Ω–æ –ù–∞—Ü–±–∞–Ω–∫ –ø—Ä–æ–≤–æ–¥–∏—Ç –æ–ø—Ä–æ—Å –ø–æ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω—É ‚Äî –∫–∞–∂–¥—ã–π –º–µ—Å—è—Ü 1500 –≤–∑—Ä–æ—Å–ª—ã—Ö –∂–∏—Ç–µ–ª–µ–π —Å—Ç—Ä–∞–Ω—ã –¥–µ–ª—è—Ç—Å—è —Å–≤–æ–∏–º–∏ –æ—â—É—â–µ–Ω–∏—è–º–∏ –æ—Ç –∏–∑–º–µ–Ω–µ–Ω–∏—è —Ü–µ–Ω. –ò, —Å—É–¥—è –ø–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º, –æ—â—É—â–µ–Ω–∏—è —É –∫–∞–∑–∞—Ö—Å—Ç–∞–Ω—Ü–µ–≤ –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏–≤—ã–µ –∏ —Ç—Ä–µ–≤–æ–∂–Ω—ã–µ. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–µ –∑–∞—è–≤–ª–µ–Ω–∏—è –æ ¬´–∑–∞–º–µ–¥–ª–µ–Ω–∏–∏ –∏–Ω—Ñ–ª—è—Ü–∏–∏¬ª, –ª—é–¥–∏ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –æ—â—É—â–∞—Ç—å —Ä–æ—Å—Ç —Ü–µ–Ω –±—É–∫–≤–∞–ª—å–Ω–æ –≤–æ –≤—Å—ë–º. - –ö—Ä–∞—Ç–∫–æ—Å—Ä–æ—á–Ω—ã–µ –æ–∂–∏–¥–∞–Ω–∏—è –ø–æ —Ä–æ—Å—Ç—É —Ü–µ–Ω –Ω–∞ –±–ª–∏–∂–∞–π—à–∏–µ 12 –º–µ—Å—è—Ü–µ–≤ ‚Äî 13,6%, - –î–æ–ª–≥–æ—Å—Ä–æ—á–Ω—ã–µ ‚Äî 14,9%, –ü—Ä–∏ —Ç–æ–º, —á—Ç–æ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∞—è –∏–Ω—Ñ–ª—è—Ü–∏—è –≤ –Ω–æ—è–±—Ä–µ ‚Äî 12,4%. –≠—Ç–æ –∑–Ω–∞—á–∏—Ç, —á—Ç–æ –∏–Ω—Ñ–ª—è—Ü–∏—è —Å—Ç–∞–ª–∞ –Ω–æ—Ä–º–æ–π, –Ω–µ—Ç –¥–æ–≤–µ—Ä–∏—è –∫ —Å—Ç–∞–±–∏–ª–∏–∑–∞—Ü–∏–∏ —Ü–µ–Ω. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ –∫–∞–∑–∞—Ö—Å—Ç–∞–Ω—Ü—ã –æ—â—É—â–∞—é—Ç —É–¥–æ—Ä–æ–∂–∞–Ω–∏–µ –±–∞–∑–æ–≤—ã—Ö —Ç–æ–≤–∞—Ä–æ–≤: ‚Ä¢ –ü—Ä–æ–¥—É–∫—Ç—ã –ø–∏—Ç–∞–Ω–∏—è ‚Äî —Ä–æ—Å—Ç –æ—Ç–º–µ—Ç–∏–ª–∏ 82,5% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö (–æ—Å–æ–±–µ–Ω–Ω–æ –º—è—Å–æ, —Ñ—Ä—É–∫—Ç—ã –∏ –æ–≤–æ—â–∏); ‚Ä¢ –ù–µ–ø—Ä–æ–¥–æ–≤–æ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ç–æ–≤–∞—Ä—ã ‚Äî —Ä–æ—Å—Ç —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ –æ–¥–µ–∂–¥—É; ‚Ä¢ –ñ–ö–• –Ω–µ–º–Ω–æ–≥–æ —Å—Ç–∞–±–∏–ª–∏–∑–∏—Ä–æ–≤–∞–ª–æ—Å—å, –Ω–æ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç –∏ –º–æ–±–∏–ª—å–Ω–∞—è —Å–≤—è–∑—å –¥–æ—Ä–æ–∂–∞—é—Ç. –ü–æ–∫–∞ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–∞—è —Å—Ç–∞—Ç–∏—Å—Ç–∏–∫–∞ –≥–æ–≤–æ—Ä–∏—Ç –æ–± ¬´—É–º–µ—Ä–µ–Ω–Ω–æ–π –∏–Ω—Ñ–ª—è—Ü–∏–∏¬ª, –∫–æ—à–µ–ª—ë–∫ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–∞ –∫–∞–∑–∞—Ö—Å—Ç–∞–Ω—Ü–µ–≤ —Ñ–∏–∫—Å–∏—Ä—É–µ—Ç —Å–æ–≤—Å–µ–º –¥—Ä—É–≥–∏–µ —Ü–∏—Ñ—Ä—ã.","{
  ""skip"": false,
  ""country"": ""Kazakhstan"",
  ""topic"": ""inflation, demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The survey conducted by the National Bank of Kazakhstan shows that despite official statements about 'slowing inflation', people still feel an increase in prices across various categories. The actual inflation rate in November was 12.4%, while expectations for short-term price increases are at 13.6% and long-term at 14.9%. This indicates that inflation has become a norm, with many consumers feeling uncertain about the stability of prices. Major concerns include rising costs of basic goods such as food (especially meat, fruits, and vegetables), medicines, and clothing. The survey also notes some stabilization in utilities but increasing costs for internet and mobile services.""
}"
2025-12-10T08:40:14+00:00,@pharmnewskz,6581,https://t.me/pharmnewskz/6581,"–ß—Ç–æ —Ç–∞–∫–æ–µ –¥–æ–±–∞–≤–ª–µ–Ω–Ω—ã–µ —Å–∞—Ö–∞—Ä–∞ –∏ –∫–∞–∫ –∏—Ö —Ä–∞—Å–ø–æ–∑–Ω–∞—Ç—å –î–æ–±–∞–≤–ª–µ–Ω–Ω—ã–µ —Å–∞—Ö–∞—Ä–∞ ‚Äî —ç—Ç–æ –Ω–µ —Ç–æ–ª—å–∫–æ –æ–±—ã—á–Ω—ã–π –±–µ–ª—ã–π —Å–∞—Ö–∞—Ä. –ö —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –æ—Ç–Ω–æ—Å—è—Ç—Å—è –≤—Å–µ –≤–∏–¥—ã —Å–∞—Ö–∞—Ä–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ –≤–≤–æ–¥—è—Ç—Å—è –≤ –ø—Ä–æ–¥—É–∫—Ç—ã –∏ –Ω–∞–ø–∏—Ç–∫–∏ –≤–æ –≤—Ä–µ–º—è –∏—Ö –ø–µ—Ä–µ—Ä–∞–±–æ—Ç–∫–∏ –∏–ª–∏ –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è. –°—é–¥–∞ –∂–µ –≤—Ö–æ–¥—è—Ç —Å–∏—Ä–æ–ø—ã, –º—ë–¥ –∏ –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ç—ã —Ñ—Ä—É–∫—Ç–æ–≤—ã—Ö –∏–ª–∏ –æ–≤–æ—â–Ω—ã—Ö —Å–æ–∫–æ–≤, –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã–µ –¥–ª—è –ø–æ–¥—Å–ª–∞—â–∏–≤–∞–Ω–∏—è. –í–∞–∂–Ω–æ: –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ —Å–∞—Ö–∞—Ä–∞, –∫–æ—Ç–æ—Ä—ã–µ –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ —Å–æ–¥–µ—Ä–∂–∞—Ç—Å—è –≤ —Ñ—Ä—É–∫—Ç–∞—Ö, –æ–≤–æ—â–∞—Ö –∏ –º–æ–ª–æ—á–Ω—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–∞—Ö, –∫ –¥–æ–±–∞–≤–ª–µ–Ω–Ω—ã–º –Ω–µ –æ—Ç–Ω–æ—Å—è—Ç—Å—è. –ï—Å–ª–∏ –≤ —Å–æ—Å—Ç–∞–≤–µ –≤–∞—à–µ–≥–æ –Ω–∞–ø–∏—Ç–∫–∞ –≤—Å—Ç—Ä–µ—á–∞—é—Ç—Å—è —Å–ª–µ–¥—É—é—â–∏–µ –∏–Ω–≥—Ä–µ–¥–∏–µ–Ω—Ç—ã, –∑–Ω–∞—á–∏—Ç, –≤—ã –ø—å—ë—Ç–µ –ø–æ–¥—Å–ª–∞—â—ë–Ω–Ω—ã–π –Ω–∞–ø–∏—Ç–æ–∫: - —Å–æ–∫ —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ —Ç—Ä–æ—Å—Ç–Ω–∏–∫–∞ (cane juice); - –∫—É–∫—É—Ä—É–∑–Ω—ã–π —Å–∏—Ä–æ–ø (corn syrup); - –¥–µ–∫—Å—Ç—Ä–æ–∑–∞ (dextrose); - —Ñ—Ä—É–∫—Ç–æ–∑–∞ (fructose); - –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ç —Ñ—Ä—É–∫—Ç–æ–≤–æ–≥–æ —Å–æ–∫–∞ (fruit juice concentrate); - –Ω–µ–∫—Ç–∞—Ä –∞–≥–∞–≤—ã (agave nectar); - –≥–ª—é–∫–æ–∑–∞ (glucose); - —Å–∏—Ä–æ–ø —Å –≤—ã—Å–æ–∫–∏–º —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ–º —Ñ—Ä—É–∫—Ç–æ–∑—ã (high fructose corn syrup); - –º—ë–¥ (honey); - —Å–æ–ª–æ–¥–æ–≤—ã–π —Å–∏—Ä–æ–ø (malt syrup); - –∫–ª–µ–Ω–æ–≤—ã–π —Å–∏—Ä–æ–ø (maple syrup); - –º–µ–ª–∞—Å—Å–∞ (molasses); - —Å—ã—Ä–æ–π —Å–∞—Ö–∞—Ä (raw sugar); - —Å–∞—Ö–∞—Ä–æ–∑–∞ (sucrose); - —Ç—Ä–æ—Å—Ç–Ω–∏–∫–æ–≤—ã–π —Å–∞—Ö–∞—Ä (sugar cane). –î–∞–∂–µ –µ—Å–ª–∏ —Å–ª–æ–≤–æ ¬´—Å–∞—Ö–∞—Ä¬ª –Ω–∞–ø—Ä—è–º—É—é –Ω–µ —É–∫–∞–∑–∞–Ω–æ –Ω–∞ —É–ø–∞–∫–æ–≤–∫–µ, –ø–æ–¥—Å–ª–∞—Å—Ç–∏—Ç–µ–ª—å –º–æ–∂–µ—Ç —Å–∫—Ä—ã–≤–∞—Ç—å—Å—è –ø–æ–¥ –¥—Ä—É–≥–∏–º –Ω–∞–∑–≤–∞–Ω–∏–µ–º.","{
  ""skip"": true
}"
2025-12-10T08:11:05+00:00,@pharmnewskz,6580,https://t.me/pharmnewskz/6580,"FDA —Å–º—è–≥—á–∞–µ—Ç –ø—Ä–∞–≤–∏–ª–∞ –¥–ª—è –ª–µ–∫–∞—Ä—Å—Ç–≤, –Ω–æ —Ö–æ—á–µ—Ç —É–∂–µ—Å—Ç–æ—á–∏—Ç—å –∏—Ö –¥–ª—è –≤–∞–∫—Ü–∏–Ω –í –°–®–ê ‚Äî –Ω–µ–æ–∂–∏–¥–∞–Ω–Ω—ã–π –ø–æ–≤–æ—Ä–æ—Ç. FDA –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ —Ä–∞–∑—Ä–µ—à–∏—Ç –≤—ã–≤–æ–¥–∏—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ —Ä—ã–Ω–æ–∫ –ø–æ—Å–ª–µ –æ–¥–Ω–æ–≥–æ –∫—Ä—É–ø–Ω–æ–≥–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≤–º–µ—Å—Ç–æ –¥–≤—É—Ö. –ò–¥–µ—è ‚Äî —É—Å–∫–æ—Ä–∏—Ç—å –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –∏–Ω–Ω–æ–≤–∞—Ü–∏–π –∏ —Å–Ω–∏–∑–∏—Ç—å –∏–∑–¥–µ—Ä–∂–∫–∏ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π. –ù–æ –ø–æ–∫–∞ –≤–µ–¥–æ–º—Å—Ç–≤–æ –¥–µ–ª–∞–µ—Ç —à–∞–≥ –∫ –ª–∏–±–µ—Ä–∞–ª–∏–∑–∞—Ü–∏–∏, –≤–Ω—É—Ç—Ä–∏ –Ω–µ–≥–æ –∑–≤—É—á–∏—Ç –ø—Ä–∏–∑—ã–≤ –∫ —É–∂–µ—Å—Ç–æ—á–µ–Ω–∏—é ‚Äî —É–∂–µ –¥–ª—è –≤–∞–∫—Ü–∏–Ω. –†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –≤–∞–∫—Ü–∏–Ω–Ω–æ–≥–æ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è –í–∏–Ω–∞–π –ü—Ä–∞—Å–∞–¥ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –æ–±—è–∑–∞—Ç—å –ø—Ä–æ–≤–æ–¥–∏—Ç—å –º–∞—Å—à—Ç–∞–±–Ω—ã–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è –¥–∞–∂–µ –¥–ª—è –æ–±–Ω–æ–≤–ª—ë–Ω–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω –ø—Ä–æ—Ç–∏–≤ –≥—Ä–∏–ø–ø–∞ –∏ COVID-19. –û–Ω —Å—Å—ã–ª–∞–µ—Ç—Å—è –Ω–∞ –Ω–µ–ø–æ–¥—Ç–≤–µ—Ä–∂–¥—ë–Ω–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –æ —Å–º–µ—Ä—Ç–µ–ª—å–Ω—ã—Ö —Å–ª—É—á–∞—è—Ö –ø–æ—Å–ª–µ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏, –∞ –±—ã–≤—à–∏–µ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–∏ FDA –Ω–∞–∑—ã–≤–∞—é—Ç –µ–≥–æ –ø–æ–∑–∏—Ü–∏—é –æ–ø–∞—Å–Ω–æ–π: –ø–æ –∏—Ö —Å–ª–æ–≤–∞–º, —ç—Ç–æ –∑–∞—Ç–æ—Ä–º–æ–∑–∏—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –Ω–æ–≤—ã—Ö –≤–∞–∫—Ü–∏–Ω –∏ –ø—Ä–∏–≤–µ–¥—ë—Ç –∫ –º–∏–ª–ª–∏–æ–Ω–∞–º –ª–∏—à–Ω–∏—Ö –∑–∞—Ç—Ä–∞—Ç. –ü–æ—ç—Ç–æ–º—É –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ ‚Äî –±—ã—Å—Ç—Ä–µ–µ, –≤–∞–∫—Ü–∏–Ω—ã ‚Äî –ø–æ–¥ –≤–æ–ø—Ä–æ—Å–æ–º. –í –°–®–ê —Å–ø–æ—Ä—è—Ç, –≥–¥–µ –ø—Ä–æ—Ö–æ–¥–∏—Ç –≥—Ä–∞–Ω—å –º–µ–∂–¥—É —Å–∫–æ—Ä–æ—Å—Ç—å—é –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å—é.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, vaccine, safety"",
  ""impact"": ""high"",
  ""english"": ""The FDA is relaxing drug approval rules but wants to tighten them for vaccines in the US. The agency allows drugs after one large clinical trial instead of two, aiming to speed up innovation and reduce costs for pharmaceutical companies. However, within the agency there's a push towards stricter regulations, even for flu and COVID-19 vaccine updates. Director of the vaccine division Vinay Prasad suggests mandatory extensive trials, citing unconfirmed deaths after vaccination. Former FDA leaders call this dangerous, saying it will slow new vaccines and cost millions. The debate is about where to draw the line between speed and safety in drug approvals.""
}"
2025-12-10T08:08:31+00:00,@pharmnewskz,6579,https://t.me/pharmnewskz/6579,"–°–∫–∞–Ω–¥–∞–ª –≤–æ–∫—Ä—É–≥ –∑–∞–∫—É–ø–∫–∏ –≤–∞–∫—Ü–∏–Ω —Ä–∞–∑–≥–æ—Ä–µ–ª—Å—è –ø–æ—Å–ª–µ –∑–∞—è–≤–ª–µ–Ω–∏–π –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–∞ –î–∏–¥–∞—Ä–∞ –°–º–∞–≥—É–ª–æ–≤–∞. –û–Ω —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç, —á—Ç–æ –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–∏–æ–±—Ä—ë–ª –≤–∞–∫—Ü–∏–Ω—ã Sanofi –ø–æ—á—Ç–∏ –Ω–∞ 150 –º–ª—Ä–¥ —Ç–≥ –∏ —á—Ç–æ –≤—ã–±–æ—Ä –ø–æ—Å—Ç–∞–≤—â–∏–∫–∞ –º–æ–≥ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞—Ç—å—Å—è –ª–æ–±–±–∏—Ä–æ–≤–∞–Ω–∏–µ–º. –≠—Ç–∏ –≤–æ–ø—Ä–æ—Å—ã ‚Äî –æ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç–∏ –∑–∞–∫—É–ø–æ–∫ –∏ –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ—Å—Ç–∏ –≤—ã–±–æ—Ä–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî —Å—Ç–∞–ª–∏ –ø—Ä–µ–¥–º–µ—Ç–æ–º —à–∏—Ä–æ–∫–æ–π –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –¥–∏—Å–∫—É—Å—Å–∏–∏. –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ—Ç–≤–µ—Ä–≥–∞–µ—Ç –æ–±–≤–∏–Ω–µ–Ω–∏—è, –∑–∞—è–≤–ª—è—è, —á—Ç–æ –≤–∞–∫—Ü–∏–Ω—ã –ø—Ä–æ—Ö–æ–¥—è—Ç –Ω–∞—É—á–Ω–æ-–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–π –æ—Ç–±–æ—Ä, —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—Ç —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è–º SAGE/–í–û–ó –∏ –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –≤ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–º –∫–∞–ª–µ–Ω–¥–∞—Ä–µ. –ö–æ–Ω—Ç–µ–∫—Å—Ç —É—Å–∏–ª–∏–≤–∞–µ—Ç —Ç–æ—Ç —Ñ–∞–∫—Ç, —á—Ç–æ –≤ 2018 –≥–æ–¥—É SEC —Å–æ–æ–±—â–∞–ª–∞ –æ —Å–ª—É—á–∞—è—Ö –∫–æ—Ä—Ä—É–ø—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–∞–∫—Ç–∏–∫ Sanofi –≤ —Ä—è–¥–µ —Å—Ç—Ä–∞–Ω, –≤–∫–ª—é—á–∞—è –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω. –ü–æ—ç—Ç–æ–º—É –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ –∫ –ª—é–±—ã–º –∫—Ä—É–ø–Ω—ã–º –∑–∞–∫—É–ø–∫–∞–º —ç—Ç–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–º–µ—Ä–Ω–æ –ø–æ–≤—ã—à–µ–Ω–æ. –î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –ø–ª–∞—Å—Ç —Å–ø–æ—Ä–æ–≤ —Å–≤—è–∑–∞–Ω —Å —Ç–∏–ø–∞–º–∏ –≤–∞–∫—Ü–∏–Ω. –¶–µ–ª—å–Ω–æ–∫–ª–µ—Ç–æ—á–Ω—ã–µ (wP) —Å—á–∏—Ç–∞—é—Ç—Å—è –±–æ–ª–µ–µ —Ä–µ–∞–∫—Ç–∏–≤–Ω—ã–º–∏, –Ω–æ –ª—É—á—à–µ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É—é—Ç –ø–µ—Ä–µ–¥–∞—á—É –∫–æ–∫–ª—é—à–∞. –ë–µ—Å–∫–ª–µ—Ç–æ—á–Ω—ã–µ (aP) –ø–µ—Ä–µ–Ω–æ—Å—è—Ç—Å—è –ª–µ–≥—á–µ, –Ω–æ –º–æ–≥—É—Ç —Ö—É–∂–µ —Å–¥–µ—Ä–∂–∏–≤–∞—Ç—å —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏–µ –∏–Ω—Ñ–µ–∫—Ü–∏–∏ –∏ —Ç—Ä–µ–±—É—é—Ç –±–æ–ª–µ–µ —á–∞—Å—Ç—ã—Ö —Ä–µ–≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–π. –ò–º–µ–Ω–Ω–æ –ø–æ—ç—Ç–æ–º—É –≤—ã–±–æ—Ä –≤ –ø–æ–ª—å–∑—É –æ–ø—Ä–µ–¥–µ–ª—ë–Ω–Ω–æ–≥–æ —Ç–∏–ø–∞ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è —Ç—Ä–µ–±—É–µ—Ç –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç–∏ –∏ —É–±–µ–¥–∏—Ç–µ–ª—å–Ω–æ–π —ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –∞—Ä–≥—É–º–µ–Ω—Ç–∞—Ü–∏–∏. –ü—Ä–∏—á–µ–º –≤ –∞–¥—Ä–µ—Å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ö–°–≠–ö –ë–µ–π—Å–µ–Ω–æ–≤–æ–π –°.–°. –±—ã–ª–∞ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∞ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–∞—è –ø–æ–∑–∏—Ü–∏—è (–í–û–ó) WHO SAGE. –ê —á—Ç–æ –ø–∏—Å–∞–ª–∞ –æ–± —ç—Ç–æ–º SAGE/–í–û–ó? –ü–æ –ø–æ–≤–æ–¥—É –≤–æ–∑–æ–±–Ω–æ–≤–ª–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –∫–æ–∫–ª—é—à–µ–º SAGE –≤—ã—Ä–∞–∑–∏–ª–∞ –æ–±–µ—Å–ø–æ–∫–æ–µ–Ω–Ω–æ—Å—Ç—å: –í –Ω–æ—è–±—Ä–µ 2012 –≥–æ–¥–∞ –°—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∞—è –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ç–∏–≤–Ω–∞—è –≥—Ä—É–ø–ø–∞ —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ (SAGE) –ø–æ –∏–º–º—É–Ω–∏–∑–∞—Ü–∏–∏ –≤—ã—Ä–∞–∑–∏–ª–∞ –æ–±–µ—Å–ø–æ–∫–æ–µ–Ω–Ω–æ—Å—Ç—å –ø–æ –ø–æ–≤–æ–¥—É –æ—á–µ–≤–∏–¥–Ω–æ–≥–æ –≤–æ–∑–æ–±–Ω–æ–≤–ª–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –∫–æ–∫–ª—é—à–µ–º –≤ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ —Ä–∞–∑–≤–∏—Ç—ã—Ö —Å—Ç—Ä–∞–Ω–∞—Ö, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –≤—ã—Å–æ–∫–∏–π —É—Ä–æ–≤–µ–Ω—å –æ—Ö–≤–∞—Ç–∞ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–µ–π. –í –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö —ç—Ç–æ –≤–æ–∑–æ–±–Ω–æ–≤–ª–µ–Ω–∏–µ –±—ã–ª–æ —Å–≤—è–∑–∞–Ω–æ —Å —Ä–æ—Å—Ç–æ–º —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –º–ª–∞–¥–µ–Ω—Ü–µ–≤ –æ—Ç –∫–æ–∫–ª—é—à–∞. –í —Å–≤—è–∑–∏ —Å —ç—Ç–∏–º, SAGE —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª–∞ —Å—Ç—Ä–∞–Ω–∞–º, —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—é—â–∏–º –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–µ—Ä–µ—Ö–æ–¥–∞ —Å —Ü–µ–ª—å–Ω–æ–∫–ª–µ—Ç–æ—á–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω –Ω–∞ –±–µ—Å–∫–ª–µ—Ç–æ—á–Ω—ã–µ, –¥–æ–∂–¥–∞—Ç—å—Å—è –¥–∞–ª—å–Ω–µ–π—à–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π SAGE –∏–ª–∏ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ —Ç—â–∞—Ç–µ–ª—å–Ω–æ –∏–∑—É—á–∏—Ç—å –ø–æ—Å–ª–µ–¥–Ω–∏–µ –¥–∞–Ω–Ω—ã–µ –æ–± —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –±–µ—Å–∫–ª–µ—Ç–æ—á–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω –ø—Ä–æ—Ç–∏–≤ –∫–æ–∫–ª—é—à–∞ –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —Ç–æ–≥–æ, —á—Ç–æ —Ç–∞–∫–æ–π –ø–µ—Ä–µ—Ö–æ–¥ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ –º–µ–Ω–µ–µ –±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω—ã–º —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –±–æ—Ä—å–±—ã —Å –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ–º. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, –ø–µ—Ä–µ—Ö–æ–¥ —Å —Ü–µ–ª—å–Ω–æ–∫–ª–µ—Ç–æ—á–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω –Ω–∞ –±–µ—Å–∫–ª–µ—Ç–æ—á–Ω—ã–µ –¥–ª—è –ø–µ—Ä–≤–∏—á–Ω–æ–π –∏–º–º—É–Ω–∏–∑–∞—Ü–∏–∏ –º–ª–∞–¥–µ–Ω—Ü–µ–≤ —Å–ª–µ–¥—É–µ—Ç —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å —Ç–æ–ª—å–∫–æ –≤ —Ç–æ–º —Å–ª—É—á–∞–µ, –µ—Å–ª–∏ –º–æ–∂–Ω–æ –≥–∞—Ä–∞–Ω—Ç–∏—Ä–æ–≤–∞—Ç—å –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–µ –≥—Ä–∞—Ñ–∏–∫–∏ –∏–º–º—É–Ω–∏–∑–∞—Ü–∏–∏ –±–æ–ª—å—à–æ–≥–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ –¥–æ–∑ (–≤–∫–ª—é—á–∞—è –Ω–µ—Å–∫–æ–ª—å–∫–æ —Ä–µ–≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–π); —ç—Ç–æ –∏–º–µ–µ—Ç —Å–µ—Ä—å—ë–∑–Ω—ã–µ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–µ –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è –∏–∑-–∑–∞ –≥–æ—Ä–∞–∑–¥–æ –±–æ–ª–µ–µ –≤—ã—Å–æ–∫–æ–π —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –±–µ—Å–∫–ª–µ—Ç–æ—á–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω –∏ –≥–æ—Ä–∞–∑–¥–æ –±–æ–ª—å—à–µ–≥–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –¥–æ–∑.","{
  ""skip"": false,
  ""country"": ""Kazakhstan"",
  ""topic"": ""tenders, import_export, shortage, demand, vaccine, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""A controversy has arisen around the procurement of vaccines after public figure Dida Samgulov claimed that the Ministry of Health purchased Sanofi vaccines for almost 150 billion tenge. He also suggested that the selection process may have been influenced by lobbying. These issues, including transparency in procurements and justification of vaccine choices, became a subject of wide public discussion. The Ministry of Health rejected these accusations, stating that the vaccines are scientifically justified, comply with SAGE/WHO recommendations, and are used in the national immunization schedule. The context highlights that in 2018, SEC reported on corruption practices by Sanofi in several countries, including Kazakhstan. Therefore, public attention to large procurements from this company is heightened. Additional controversy surrounds the types of vaccines: whole-cell (wP) are more reactive but better control the transmission of pertussis, while acellular (aP) are easier to administer but may not as effectively contain infection and require more frequent revaccinations. The selection between these types requires"
2025-12-10T08:06:38+00:00,@pharmnewskz,6578,https://t.me/pharmnewskz/6578,"–ß—Ç–æ –≤—ã–±—Ä–∞—Ç—å –¥–ª—è –±—ã—Å—Ç—Ä–æ–≥–æ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ–≥–æ –æ–±–µ–∑–±–æ–ª–∏–≤–∞–Ω–∏—è? –ü–æ–∫—É–ø–∞—Ç–µ–ª—å —Å –±–æ–ª—å—é ‚Äî —á–∞—Å—Ç—ã–π –ø–æ—Å–µ—Ç–∏—Ç–µ–ª—å –∞–ø—Ç–µ–∫–∏. –ß—Ç–æ –Ω–∞–¥–æ –∑–Ω–∞—Ç—å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç—É –¥–ª—è —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ù–ü–í–ü? –†–∞–∑–±–µ—Ä—ë–º –Ω–∞ –ø—Ä–∏–º–µ—Ä–µ –¥–≤—É—Ö –ø–æ–ø—É–ª—è—Ä–Ω—ã—Ö —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî —ç—Ç–æ—Ä–∏–∫–æ–∫—Å–∏–±–∞ –∏ –Ω–∞–ø—Ä–æ–∫—Å–µ–Ω–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ –æ–±—Å—É–∂–¥–µ–Ω–∏—è –∏ –∫–æ–Ω—Å–µ–Ω—Å—É—Å–∞ –ø–æ –ù–ü–í–ü (2024). –í–∞–∂–Ω–æ –ø–æ–Ω–∏–º–∞—Ç—å –Ω–µ —Ç–æ–ª—å–∫–æ –∏—Ö —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å, –Ω–æ –∏ –ø—Ä–æ—Ñ–∏–ª—å –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏, –∫–æ—Ç–æ—Ä—ã–π –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç –≤—ã–±–æ—Ä. –û–±–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏–º–µ—é—Ç –≤—ã—Å–æ–∫—É—é –±–∏–æ–¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –∏ —Ö–æ—Ä–æ—à—É—é –≤—Å–∞—Å—ã–≤–∞–µ–º–æ—Å—Ç—å, –Ω–æ –∏—Ö –∫–ª—é—á–µ–≤—ã–µ —Ä–∞–∑–ª–∏—á–∏—è –ª–µ–∂–∞—Ç –≤ –¥–≤—É—Ö –ø–ª–æ—Å–∫–æ—Å—Ç—è—Ö: —Å–∫–æ—Ä–æ—Å—Ç—å –∏ –¥–ª–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –¥–µ–π—Å—Ç–≤–∏—è, –∞ —Ç–∞–∫–∂–µ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω–∞—è –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –¥–ª—è —Ä–∞–∑–Ω—ã—Ö —Å–∏—Å—Ç–µ–º –æ—Ä–≥–∞–Ω–∏–∑–º–∞. –≠—Ç–æ—Ä–∏–∫–æ–∫—Å–∏–± –Ω–∞—á–∏–Ω–∞–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å —á–µ—Ä–µ–∑ 20‚Äì25 –º–∏–Ω—É—Ç, –Ω–æ –µ–≥–æ –≥–ª–∞–≤–Ω–æ–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–æ ‚Äî –¥–µ–π—Å—Ç–≤–∏–µ –¥–æ 24 —á–∞—Å–æ–≤ –±–ª–∞–≥–æ–¥–∞—Ä—è –¥–ª–∏—Ç–µ–ª—å–Ω–æ–º—É –ø–µ—Ä–∏–æ–¥—É –ø–æ–ª—É–≤—ã–≤–µ–¥–µ–Ω–∏—è. –≠—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ–≥–æ –ø—Ä–∏—ë–º–∞ –≤ —Å—É—Ç–∫–∏. –ï–≥–æ —Å–∏–ª—å–Ω–∞—è —Å—Ç–æ—Ä–æ–Ω–∞ ‚Äî –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –ª—É—á—à–∞—è –ø–µ—Ä–µ–Ω–æ—Å–∏–º–æ—Å—Ç—å —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –∂–µ–ª—É–¥–æ—á–Ω–æ-–∫–∏—à–µ—á–Ω–æ–≥–æ —Ç—Ä–∞–∫—Ç–∞. –ß–∞—Å—Ç–æ—Ç–∞ —Å–µ—Ä—å—ë–∑–Ω—ã—Ö –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π, —Ç–∞–∫–∏—Ö –∫–∞–∫ —è–∑–≤—ã –∏–ª–∏ –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏—è, –ø—Ä–∏–º–µ—Ä–Ω–æ –≤ –¥–≤–∞ —Ä–∞–∑–∞ –Ω–∏–∂–µ, —á–µ–º —É –Ω–µ—Å–µ–ª–µ–∫—Ç–∏–≤–Ω—ã—Ö –ù–ü–í–ü. –ù–∞–ø—Ä–æ–∫—Å–µ–Ω, –æ—Å–æ–±–µ–Ω–Ω–æ –≤ —Ñ–æ—Ä–º–µ –Ω–∞—Ç—Ä–∏–µ–≤–æ–π —Å–æ–ª–∏, –º–æ–∂–µ—Ç –æ–±–µ—Å–ø–µ—á–∏–≤–∞—Ç—å –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏–π —ç—Ñ—Ñ–µ–∫—Ç —É–∂–µ —á–µ—Ä–µ–∑ 15 –º–∏–Ω—É—Ç, –Ω–æ —Ç—Ä–µ–±—É–µ—Ç –¥–≤—É–∫—Ä–∞—Ç–Ω–æ–≥–æ –ø—Ä–∏—ë–º–∞ –≤ —Å—É—Ç–∫–∏. –ï–≥–æ –≥–ª–∞–≤–Ω–æ–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–æ ‚Äî —Å–∞–º—ã–π –±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω—ã–π –ø—Ä–æ—Ñ–∏–ª—å —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç–æ–π –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ —Å—Ä–µ–¥–∏ –ù–ü–í–ü. –î–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–∞ —Å –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ —Ä–∏—Å–∫–∞–º–∏, –≥–∏–ø–µ—Ä—Ç–æ–Ω–∏–µ–π –∏–ª–∏ –ø–æ—Å–ª–µ –∏–Ω—Ñ–∞—Ä–∫—Ç–∞ –Ω–∞–ø—Ä–æ–∫—Å–µ–Ω —á–∞—Å—Ç–æ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –≤—ã–±–æ—Ä–∞, —Ç–∞–∫ –∫–∞–∫ –º–µ–Ω—å—à–µ –≤–ª–∏—è–µ—Ç –Ω–∞ —Ä–∏—Å–∫ —Ç—Ä–æ–º–±–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –∏ –Ω–µ –ø–æ–≤—ã—à–∞–µ—Ç —á–∞—Å—Ç–æ—Ç—É —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, –≤—ã–±–æ—Ä —Å–º–µ—â–∞–µ—Ç—Å—è –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç –∞–Ω–∞–º–Ω–µ–∑–∞ –ø–æ–∫—É–ø–∞—Ç–µ–ª—è: –ø—Ä–∏ —Ä–∏—Å–∫–∞—Ö —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –ñ–ö–¢ –ø—Ä–µ–¥–ø–æ—á—Ç–∏—Ç–µ–ª—å–Ω–µ–µ —ç—Ç–æ—Ä–∏–∫–æ–∫—Å–∏–±, –ø—Ä–∏ –∫–∞—Ä–¥–∏–æ—Ä–∏—Å–∫–∞—Ö ‚Äî –Ω–∞–ø—Ä–æ–∫—Å–µ–Ω. –î–∞–Ω–Ω—ã–µ –º–∞—Å—à—Ç–∞–±–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—Ç: —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≤ –æ–±–µ–∑–±–æ–ª–∏–≤–∞–Ω–∏–∏ —É –Ω–∏—Ö —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º–∞, –Ω–æ –ø—Ä–æ—Ñ–∏–ª–∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ —Ä–∞–∑–ª–∏—á–Ω—ã. –ò—Ç–æ–≥: –¥–ª—è –¥–æ–ª–≥–æ–π —Ç–µ—Ä–∞–ø–∏–∏ —Å –∞–∫—Ü–µ–Ω—Ç–æ–º –Ω–∞ –∂–µ–ª—É–¥–æ–∫ ‚Äî —ç—Ç–æ—Ä–∏–∫–æ–∫—Å–∏–±, –¥–ª—è –±—ã—Å—Ç—Ä–æ–≥–æ –æ–±–µ–∑–±–æ–ª–∏–≤–∞–Ω–∏—è —Å –∞–∫—Ü–µ–Ω—Ç–æ–º –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ —Å–µ—Ä–¥—Ü–∞ ‚Äî –Ω–∞–ø—Ä–æ–∫—Å–µ–Ω. –í—Å–µ–≥–¥–∞ —É—Ç–æ—á–Ω—è–π—Ç–µ –Ω–∞–ª–∏—á–∏–µ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —É –ø–æ–∫—É–ø–∞—Ç–µ–ª—è –ø–µ—Ä–µ–¥ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–µ–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, safety, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""This discussion focuses on choosing between etoricoxib and naproxen for quick and safe pain relief. Both are effective but differ in their onset of action (20-25 minutes vs 15 minutes), duration of effect (up to 24 hours vs twice daily), and safety profiles, which affect the recommendation. Etoricoxib is better tolerated by the gastrointestinal tract with a lower risk of serious complications like ulcers or bleeding. Naproxen has a favorable cardiovascular profile but requires twice-daily dosing. The choice depends on patient history: for GI risks, etoricoxib is preferred; for cardiac risks, naproxen is recommended. Both have comparable pain relief efficacy but different safety profiles.""
}"
2025-12-10T08:05:39+00:00,@pharmnewskz,6577,https://t.me/pharmnewskz/6577,"–ï—â—ë –æ–¥–Ω–∞ –æ—Ç—Å—Ç–∞–≤–∫–∞ –≤ —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –í–∏—Ü–µ-–º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ê—Ä–¥–∞–∫ –ê–º–∞–Ω–≥–µ–ª—å–¥–∏–µ–≤ –ø–æ–∫–∏–Ω—É–ª —Å–≤–æ–π –ø–æ—Å—Ç ‚Äî –ø–æ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∂–µ–ª–∞–Ω–∏—é, —Å–æ–æ–±—â–∏–ª–∏ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ. –ù–∞ —ç—Ç–æ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –æ–Ω –ø—Ä–æ—Ä–∞–±–æ—Ç–∞–ª —á—É—Ç—å –±–æ–ª—å—à–µ –≥–æ–¥–∞, –∫—É—Ä–∏—Ä—É—è —Ñ–∏–Ω–∞–Ω—Å–æ–≤—É—é —Å—Ñ–µ—Ä—É. –ê–º–∞–Ω–≥–µ–ª—å–¥–∏–µ–≤ ‚Äî —ç–∫–æ–Ω–æ–º–∏—Å—Ç —Å –±–æ–ª—å—à–∏–º –æ–ø—ã—Ç–æ–º —Ä–∞–±–æ—Ç—ã –≤ –≥–æ—Å—Ñ–∏–Ω–∞–Ω—Å–∞—Ö. –†–∞–Ω–µ–µ –æ–Ω –∑–∞–Ω–∏–º–∞–ª –ø–æ—Å—Ç –≤–∏—Ü–µ-–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –µ—â—ë –≤ 2004‚Äì2006 –≥–æ–¥–∞—Ö, –∞ —Ç–∞–∫–∂–µ —Ä–∞–±–æ—Ç–∞–ª –≤ –ú–∏–Ω—Ñ–∏–Ω–µ, –ù–∞—Ü–±–∞–Ω–∫–µ –∏ –ú–§–¶–ê. –ï–≥–æ –º–µ—Å—Ç–æ –ø–æ–∫–∞ –æ—Å—Ç–∞—ë—Ç—Å—è –≤–∞–∫–∞–Ω—Ç–Ω—ã–º. –≠—Ç–æ –≤—Ç–æ—Ä–∞—è –∫—Ä—É–ø–Ω–∞—è –æ—Ç—Å—Ç–∞–≤–∫–∞ –≤ –¥–µ–∫–∞–±—Ä–µ. 1 –¥–µ–∫–∞–±—Ä—è —É—à—ë–ª –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –§–æ–Ω–¥–∞ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏—è –ê–π–¥—ã–Ω –ö—É–ª—å—Å–µ–∏—Ç–æ–≤ ‚Äî –æ–Ω –ø—Ä–æ–¥–µ—Ä–∂–∞–ª—Å—è –Ω–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –≤–æ—Å–µ–º—å –º–µ—Å—è—Ü–µ–≤ –∏ —Å—Ç–∞–ª —É–∂–µ –ø—è—Ç—ã–º —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–º –§–°–ú–° –∑–∞ –ø—è—Ç—å –ª–µ—Ç. –û—Ç—Å—Ç–∞–≤–∫–∏ –ø—Ä–æ–∏—Å—Ö–æ–¥—è—Ç –Ω–∞ —Ñ–æ–Ω–µ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–≥–æ –∫—Ä–∏–∑–∏—Å–∞ –≤ —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ë–æ–ª—å–Ω–∏—Ü—ã –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –ª–µ—á–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ –¥–æ–ª–≥ ‚Äî —Ñ–æ–Ω–¥ –¥–æ–ª–∂–µ–Ω –∫–ª–∏–Ω–∏–∫–∞–º —Å–æ—Ç–Ω–∏ –º–∏–ª–ª–∏–∞—Ä–¥–æ–≤ —Ç–µ–Ω–≥–µ. –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏—â–µ—Ç –Ω–æ–≤—ã—Ö —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π.","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""hospital_policy, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Ardak Amangeldyev, a former vice-minister of health who worked in the financial sphere for over a year, resigned from his position. This is the second major resignation in December, following Aida Kulesseitov's departure as chairman of the Social Medical Insurance Fund after eight months. These resignations occur against the backdrop of a financial crisis in the healthcare system where hospitals are still treating patients in debt and the fund owes hundreds of billions of tenge to clinics. The Ministry of Health is searching for new leaders.""
}"
2025-12-10T06:29:31+00:00,@pharmnewskz,6576,https://t.me/pharmnewskz/6576,"–ü—Ä–∏–∫–∞–∑–æ–º –ú–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–µ—Å–ø—É–±–ª–∏–∫–∏ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω –æ—Ç 3 –¥–µ–∫–∞–±—Ä—è 2025 –≥–æ–¥–∞ ‚Ññ 158 –≤–Ω–µ—Å–µ–Ω—ã –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ü—Ä–µ–¥–µ–ª—å–Ω—ã–µ —Ü–µ–Ω—ã –Ω–∞ —Ç–æ—Ä–≥–æ–≤–æ–µ –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –≤ —Ä–∞–º–∫–∞—Ö –≥–∞—Ä–∞–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –æ–±—ä–µ–º–∞ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –∏ (–∏–ª–∏) –≤ —Å–∏—Å—Ç–µ–º–µ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–≥–æ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏—è. –ü—Ä–∏–∫–∞–∑ –≤–≤–æ–¥–∏—Ç—Å—è –≤ –¥–µ–π—Å—Ç–≤–∏–µ —Å 19 –¥–µ–∫–∞–±—Ä—è 2025 –≥–æ–¥–∞. –ò–∑–º–µ–Ω–µ–Ω–∏—è –∫–∞—Å–∞—é—Ç—Å—è –ø—Ä–µ–¥–µ–ª—å–Ω—ã—Ö —Ü–µ–Ω –Ω–∞ –æ—Ç–¥–µ–ª—å–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –∑–∞–∫—É–ø–∞–ª–∏—Å—å —Ä–∞–Ω–µ–µ –ï–¥–∏–Ω—ã–º –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–º –¢–û–û ¬´–°–ö-–§–∞—Ä–º–∞—Ü–∏—è¬ª, –∏ –±—É–¥—É—Ç –ø—Ä–∏–æ–±—Ä–µ—Ç–∞—Ç—å—Å—è –Ω–∞ 2026 –≥–æ–¥ –≤ —Ä–∞–º–∫–∞—Ö –ì–û–ë–ú–ü –∏ –û–°–ú–°. –û–∑–Ω–∞–∫–æ–º–∏—Ç—å—Å—è —Å–æ —Å–ø–∏—Å–∫–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –Ω–∞ –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–∏–∫–∞–∑–æ–º –∏–∑–º–µ–Ω–µ–Ω—ã –ø—Ä–µ–¥–µ–ª—å–Ω—ã–µ —Ü–µ–Ω—ã –Ω–∞ —Ç–æ—Ä–≥–æ–≤–æ–µ –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –≤ —Ä–∞–º–∫–∞—Ö –≥–∞—Ä–∞–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –æ–±—ä–µ–º–∞ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –∏ (–∏–ª–∏) –≤ —Å–∏—Å—Ç–µ–º–µ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–≥–æ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏—è –º–æ–∂–Ω–æ –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ: https://pharmnewskz.com/ru/legislation/prikaz-ministra-zdravoohraneniya-rk-ot-3-dekabrya-2025-goda--158_10408","{
  ""skip"": false,
  ""country"": ""–ö–∞–∑–∞—Ö—Å—Ç–∞–Ω"",
  ""topic"": ""regulation, reimbursement, pricing"",
  ""impact"": ""high"",
  ""english"": ""The Decree of the Ministry of Health of the Republic of Kazakhstan dated December 3, 2025, No. 158, introduces changes to the Maximum Prices for Trade Names of Medicinal Products and Medical Devices within Guaranteed Volume of Free Healthcare and (or) in the System of Compulsory Social Medical Insurance. The Decree comes into effect on December 19, 2025. Changes affect maximum prices for certain medicinal products that were not previously purchased by Unified Distributor TEO ¬´SK-Farmacia¬ª and will be acquired for 2026 within Guaranteed Volume of Free Healthcare and Compulsory Social Medical Insurance. The list of medicines whose maximum price has been changed can be found on the portal: https://pharmnewskz.com/ru/legislation/prikaz-ministra-zdravoohraneniya-rk-ot-3-dekabrya-2025-goda--158_10408.""
}"
2025-12-10T06:29:13+00:00,@pharmnewskz,6575,https://t.me/pharmnewskz/6575,"–° –º–æ–º–µ–Ω—Ç–∞ –≤–Ω–µ–¥—Ä–µ–Ω–∏—è —Ü–∏—Ñ—Ä–æ–≤–æ–≥–æ —Å–µ—Ä–≤–∏—Å–∞ ¬´–°–æ—Ü–∏–∞–ª—å–Ω—ã–π –∫–æ—à–µ–ª–µ–∫¬ª –≥—Ä–∞–∂–¥–∞–Ω–∞–º –±—ã–ª–æ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–æ —Å–≤—ã—à–µ 13 –º–ª–Ω —É—Å–ª—É–≥ –ø–æ –≤—ã–¥–∞—á–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —É–¥–æ–±–Ω–æ–º —Ü–∏—Ñ—Ä–æ–≤–æ–º —Ñ–æ—Ä–º–∞—Ç–µ, —á—Ç–æ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 81,2% –≤—Å–µ—Ö –≤—ã–ø–∏—Å–∞–Ω–Ω—ã—Ö –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–π –≤ —Ä–∞–º–∫–∞—Ö –∞–º–±—É–ª–∞—Ç–æ—Ä–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è (–ê–õ–û), ‚Äì —Å–æ–æ–±—â–∞–µ—Ç –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–∞ –ú–ó –†–ö. –ö –ø—Ä–æ–µ–∫—Ç—É –ø–æ–¥–∫–ª—é—á–µ–Ω—ã 708 –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ø–æ –≤—Å–µ–π —Å—Ç—Ä–∞–Ω–µ. –û–±—â–∏–π —É—Ä–æ–≤–µ–Ω—å –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –¥–æ—Å—Ç–∏–≥ 85,1%, –≤–∫–ª—é—á–∞—è —Ä–µ—Ü–µ–ø—Ç—ã, –æ—Ç–ø—É—â–µ–Ω–Ω—ã–µ —á–µ—Ä–µ–∑ —Ü–∏—Ñ—Ä–æ–≤—ã–µ –º–µ—Ö–∞–Ω–∏–∑–º—ã e-Densaulyq, Halyk, –í–¶–ö, Face ID –∏ SMS-–∫–æ–¥. 14,9% —Ä–µ—Ü–µ–ø—Ç–æ–≤ –≤—ã–ø–æ–ª–Ω—è—é—Ç—Å—è –≤ –ø—Ä–µ–∂–Ω–µ–º –±—É–º–∞–∂–Ω–æ–º —Ñ–æ—Ä–º–∞—Ç–µ ‚Äî —ç—Ç–æ –≤–∞–∂–Ω–æ –¥–ª—è –≥—Ä–∞–∂–¥–∞–Ω –±–µ–∑ —Å–º–∞—Ä—Ç—Ñ–æ–Ω–æ–≤ –∏ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–∞, –∞ —Ç–∞–∫–∂–µ –º–∞–ª–æ–º–æ–±–∏–ª—å–Ω—ã—Ö –≥—Ä–∞–∂–¥–∞–Ω, –ø–æ–∂–∏–ª—ã—Ö –ª—é–¥–µ–π –∏ –¥–µ—Ç–µ–π. –ê–ª–≥–æ—Ä–∏—Ç–º –ø–æ–ª—É—á–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ–ª–Ω–æ—Å—Ç—å—é –∞–≤—Ç–æ–º–∞—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω: –í—Ä–∞—á —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç —Ä–µ—Ü–µ–ø—Ç –≤ –ò–°–õ–û –ú–ó –†–ö, –∫–æ—Ç–æ—Ä—ã–π –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏ –ø–æ—è–≤–ª—è–µ—Ç—Å—è –≤ ¬´–°–æ—Ü–∏–∞–ª—å–Ω–æ–º –∫–æ—à–µ–ª—å–∫–µ¬ª –º–æ–±–∏–ª—å–Ω–æ–≥–æ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è eGov mobile –≤ –≤–∏–¥–µ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–≥–æ –≤–∞—É—á–µ—Ä–∞. –ü–∞—Ü–∏–µ–Ω—Ç –ø—Ä–µ–¥—ä—è–≤–ª—è–µ—Ç –≤–∞—É—á–µ—Ä –≤ –∞–ø—Ç–µ–∫–µ ‚Äî –æ–Ω –æ—Ç–æ–±—Ä–∞–∂–∞–µ—Ç—Å—è –∫–∞–∫ QR-–∫–æ–¥. –ü—Ä–æ–≤–∏–∑–æ—Ä —Å–∫–∞–Ω–∏—Ä—É–µ—Ç QR-–∫–æ–¥ –∏ –≤—ã–¥–∞–µ—Ç –Ω–∞–∑–Ω–∞—á–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –≠—Ç–æ –ø–æ–∑–≤–æ–ª—è–µ—Ç: ‚û§ –∏—Å–∫–ª—é—á–∏—Ç—å —Ä—É—á–Ω–æ–π –≤–≤–æ–¥ –¥–∞–Ω–Ω—ã—Ö; ‚û§ —Å–æ–∫—Ä–∞—Ç–∏—Ç—å –≤—Ä–µ–º—è –æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏—è; ‚û§ –æ–±–µ—Å–ø–µ—á–∏—Ç—å –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç—å –∏ —Ç–æ—á–Ω—ã–π –∫–æ–Ω—Ç—Ä–æ–ª—å –æ—Ç–ø—É—Å–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤.","{
  ""skip"": false,
  ""country"": ""Kazakhstan"",
  ""topic"": ""demand, clinical_trial, hospital_policy"",
  ""impact"": ""high"",
  ""english"": ""The digital service 'Social Wallet' has provided over 13 million services for the issuance of medicines in a convenient digital format. This accounts for 81.2% of all prescriptions issued under ambulatory drug supply (ADL) in Kazakhstan. The project is now available to 708 medical organizations across the country. Overall, the level of medication provision has reached 85.1%, including prescriptions dispensed through e-Densaulyq, Halyk, VCK, Face ID and SMS-code mechanisms. 14.9% of prescriptions are still issued in a traditional paper format - this is important for citizens without smartphones or internet access, as well as those with mobility issues, elderly people, children, etc. The entire process of obtaining medications is fully automated: the doctor forms a prescription in the MZR Kazakhstan ISLO system, which automatically appears in the eGov mobile app's electronic voucher format. Patients present the voucher at the pharmacy - it is displayed as a QR code. The pharmacist scans the QR code and dispenses"
2025-12-10T06:28:05+00:00,@pharmnewskz,6574,https://t.me/pharmnewskz/6574,"–í –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–µ —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ —Ç–æ–ª—å–∫–æ —Ç—Ä–∏ —á–µ–ª–æ–≤–µ–∫–∞, –ø—Ä–æ—à–µ–¥—à–∏—Ö –ø–æ–ª–Ω—ã–π –∫—É—Ä—Å –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏, –∑–∞—Ä–∞–∑–∏–ª–∏—Å—å –∫–æ–∫–ª—é—à–µ–º. –û–± —ç—Ç–æ–º —Å–æ–æ–±—â–∏–ª–∏ –≤ –ö–æ–º–∏—Ç–µ—Ç–µ —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-—ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –≤ –æ—Ç–≤–µ—Ç–µ –Ω–∞ –∑–∞–ø—Ä–æ—Å Informburo.kz. –° –Ω–∞—á–∞–ª–∞ 2025 –≥–æ–¥–∞ –∫–æ–∫–ª—é—à–µ–º –∑–∞—Ä–∞–∑–∏–ª–∏—Å—å 390 —á–µ–ª–æ–≤–µ–∫, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö 383 —Ä–µ–±—ë–Ω–∫–∞ –∏ —Å–µ–º—å –≤–∑—Ä–æ—Å–ª—ã—Ö. –ò–∑ –Ω–∏—Ö: 346 —á–µ–ª–æ–≤–µ–∫ ‚Äì –Ω–µ –ø—Ä–∏–≤–∏–≤–∞–ª–∏—Å—å; —Ç—Ä–æ–µ –ø—Ä–æ—à–ª–∏ –ø–æ–ª–Ω—ã–π –∫—É—Ä—Å –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏; 33 ‚Äì –Ω–µ —É—Å–ø–µ–ª–∏ –∑–∞–≤–µ—Ä—à–∏—Ç—å –∏–º–º—É–Ω–∏–∑–∞—Ü–∏—é; 8 ‚Äì –Ω–µ–∏–∑–≤–µ—Å—Ç–Ω–æ, –ø—Ä–∏–≤–∏–≤–∞–ª–∏—Å—å —Ä–∞–Ω–µ–µ –∏–ª–∏ –Ω–µ—Ç. –ü–ª–∞–Ω–æ–≤—É—é –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏—é –ø—Ä–æ—Ç–∏–≤ –∫–æ–∫–ª—é—à–∞ –∑–∞ 10 –º–µ—Å—è—Ü–µ–≤ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –ø—Ä–æ—à–ª–∏: 246 —Ç—ã—Å—è—á –¥–µ—Ç–µ–π –¥–æ –æ–¥–Ω–æ–≥–æ –≥–æ–¥–∞ (82,1% –æ—Ç –ø–æ–¥–ª–µ–∂–∞—â–∏—Ö –∏–º–º—É–Ω–∏–∑–∞—Ü–∏–∏); 267,7 —Ç—ã—Å—è—á–∏ –¥–µ—Ç–µ–π –æ–¥–Ω–æ–≥–æ –≥–æ–¥–∞ (–æ—Ö–≤–∞—Ç 78%); 281,4 —Ç—ã—Å—è—á–∏ –¥–µ—Ç–µ–π —à–µ—Å—Ç–∏ –ª–µ—Ç (–æ—Ö–≤–∞—Ç ‚Äì 76,4%). –ü—Ä–∏ —ç—Ç–æ–º –æ–ø—Ç–∏–º–∞–ª—å–Ω—ã–º —É—Ä–æ–≤–Ω–µ–º –æ—Ö–≤–∞—Ç–∞ —Å—á–∏—Ç–∞–µ—Ç—Å—è 79,2%.","{
  ""skip"": false,
  ""country"": ""Kazakhstan"",
  ""topic"": ""epidemic,safety,vaccine"",
  ""impact"": ""medium"",
  ""english"": ""In the first ten months of 2025, only three people who completed a full course of vaccination against measles in Kazakhstan have contracted measles. This information was provided by the Committee for Sanitary and Epidemiological Control in response to a query from Informburo.kz. Since the beginning of this year, 390 cases of measles were reported, including 383 children and seven adults. Among them: 346 individuals did not receive vaccination; three completed the full course of vaccinations; 33 had not finished their immunization process; eight have unknown vaccination history. For measles vaccination in the first ten months of this year, 246 thousand children under one year old (82.1% coverage), 267.7 thousand children aged one year (coverage at 78%), and 281.4 thousand children aged six years (coverage at 76.4%) have been vaccinated. The optimal level of coverage is 79.2%. ""
}"
2025-12-10T06:26:35+00:00,@pharmnewskz,6573,https://t.me/pharmnewskz/6573,"–° –Ω–∞—á–∞–ª–∞ 2025 –≥–æ–¥–∞ –≥–æ–¥–∞ –ø–æ—á—Ç–∏ 19 —Ç—ã—Å—è—á –∫–∞–∑–∞—Ö—Å—Ç–∞–Ω—Ü–µ–≤ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ –æ—Ç–∫–∞–∑–∞–ª–∏—Å—å –æ—Ç –ø—Ä–∏–≤–∏–≤–æ–∫. –≠—Ç–æ –≤ —Ä–∞–∑—ã –±–æ–ª—å—à–µ, —á–µ–º –≤–æ—Å–µ–º—å –ª–µ—Ç –Ω–∞–∑–∞–¥, –∫–æ–≥–¥–∞ –ø–æ–¥–æ–±–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ –±—ã–ª–æ –ø–æ—Ä—è–¥–∫–∞ –ø—è—Ç–∏ —Ç—ã—Å—è—á. –ì–ª–∞–≤–Ω—ã–π —ç–∫—Å–ø–µ—Ä—Ç —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –ö–æ–º–∏—Ç–µ—Ç–∞ —Å–∞–Ω—ç–ø–∏–¥–∫–æ–Ω—Ç—Ä–æ–ª—è –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–ö –ú–∞–¥–∏–Ω–∞ –û—Ä—ã—Å–ø–∞–µ–≤–∞ –æ—Ç–º–µ—á–∞–µ—Ç, —á—Ç–æ –ª—é–±–æ–π –æ—Ç–∫–∞–∑ –æ—Ç –ø—Ä–∏–≤–∏–≤–æ–∫ –≤–ª–∏—è–µ—Ç –Ω–∞ —Å–Ω–∏–∂–µ–Ω–∏–µ –∫–æ–ª–ª–µ–∫—Ç–∏–≤–Ω–æ–≥–æ –∏–º–º—É–Ω–∏—Ç–µ—Ç–∞. –î–∞–Ω–Ω–∞—è —Å–∏—Ç—É–∞—Ü–∏—è –º–æ–∂–µ—Ç –≤—ã–∑–≤–∞—Ç—å –≤—Å–ø—ã—à–∫—É –≤–∞–∫—Ü–∏–æ–Ω–æ—É–ø—Ä–∞–≤–ª—è–µ–º—ã—Ö –±–æ–ª–µ–∑–Ω–µ–π. "" –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ –æ—Ç–∫–∞–∑–æ–≤ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–∏ –≤ –ê—Å—Ç–∞–Ω–µ, –ê–ª–º–∞—Ç—ã, –∞ —Ç–∞–∫–∂–µ –≤ –ê—Ç—ã—Ä–∞—É—Å–∫–æ–π –∏ –ú–∞–Ω–≥–∏—Å—Ç–∞—É—Å–∫–æ–π –æ–±–ª–∞—Å—Ç—è—Ö. –õ—é–¥–∏ —á–∞—â–µ –≤—Å–µ–≥–æ –Ω–∞–∑—ã–≤–∞—é—Ç –æ–¥–Ω–∏ –∏ —Ç–µ –∂–µ –ø—Ä–∏—á–∏–Ω—ã: —Å–æ–º–Ω–µ–Ω–∏—è –≤ –∫–∞—á–µ—Å—Ç–≤–µ –≤–∞–∫—Ü–∏–Ω, –æ—Ç—Å—É—Ç—Å–≤–∏–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏, —Ä–µ–ª–∏–≥–∏–æ–∑–Ω—ã–µ –∏–ª–∏ –∏–¥–µ–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ —É–±–µ–∂–¥–µ–Ω–∏—è"", - –≥–æ–≤–æ—Ä–∏—Ç —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç.","{
  ""skip"": false,
  ""country"": ""Kazakhstan"",
  ""topic"": ""demand,safety,vaccine"",
  ""impact"": ""high"",
  ""english"": ""Almost 19,000 Kazakhstani citizens officially refused vaccinations from the beginning of 2025. This is significantly more than eight years ago when around five thousand cases were reported. The main expert at the Committee for Sanitary and Epidemiological Control of the Ministry of Health of Kazakhstan, Madina Oryspayeva, noted that any refusal to vaccinate affects a decrease in collective immunity. Such situation may lead to outbreaks of vaccine-preventable diseases. Most refusals were recorded in Astana, Almaty, as well as Atyrau and Mangistau regions. People most often cite the same reasons: doubts about the quality of vaccines, lack of information, religious or ideological beliefs.""
}"
2025-12-10T06:25:38+00:00,@pharmnewskz,6572,https://t.me/pharmnewskz/6572,"–ë–ª–∞–≥–æ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω—ã–µ —Ñ–æ–Ω–¥—ã –∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø–æ –≤—Å–µ–º—É –º–∏—Ä—É –≤—ã—Ä–∞–∑–∏–ª–∏ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç—å –≤—ã–¥–µ–ª–∏—Ç—å 1,9 –º–ª—Ä–¥ –¥–æ–ª–ª–∞—Ä–æ–≤ –°–®–ê –Ω–∞ –±–æ—Ä—å–±—É —Å –ø–æ–ª–∏–æ–º–∏–µ–ª–∏—Ç–æ–º. –≠—Ç–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞ –ø–æ–∑–≤–æ–ª—è—Ç –µ–∂–µ–≥–æ–¥–Ω–æ –∑–∞—â–∏—â–∞—Ç—å –æ—Ç –≤–∏—Ä—É—Å–∞ 370 –º–∏–ª–ª–∏–æ–Ω–æ–≤ –¥–µ—Ç–µ–π. –£–∂–µ –≤ 2026 –≥–æ–¥—É –±—é–¥–∂–µ—Ç –ì–ª–æ–±–∞–ª—å–Ω–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã –ø–æ –ª–∏–∫–≤–∏–¥–∞—Ü–∏–∏ –ø–æ–ª–∏–æ–º–∏–µ–ª–∏—Ç–∞ (GPEI) —Å–æ–∫—Ä–∞—Ç–∏—Ç—Å—è –Ω–∞ 30%, –∞ –∫ 2029 –≥–æ–¥—É –¥–µ—Ñ–∏—Ü–∏—Ç —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è —Å–æ—Å—Ç–∞–≤–∏—Ç 1,7 –º–ª—Ä–¥ –¥–æ–ª–ª–∞—Ä–æ–≤ –°–®–ê. –¢–∞–∫–∞—è —Å–∏—Ç—É–∞—Ü–∏—è –≤ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–π —Å—Ç–µ–ø–µ–Ω–∏ –æ–±—É—Å–ª–æ–≤–ª–µ–Ω–∞ –æ—Ç–∫–∞–∑–æ–º —Ü–µ–ª–æ–≥–æ —Ä—è–¥–∞ —Å—Ç—Ä–∞–Ω, –≤–∫–ª—é—á–∞—è –°–®–ê, –æ—Ç —É—á–∞—Å—Ç–∏—è –≤ –ø—Ä–æ–≥—Ä–∞–º–º–∞—Ö —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è. –û —Å–æ–∫—Ä–∞—â–µ–Ω–∏–∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–π –ø–æ–º–æ—â–∏ –æ–±—ä—è–≤–∏–ª–∏ —Ç–∞–∫–∏–µ —Å—Ç—Ä–∞–Ω—ã, –∫–∞–∫ –ì–µ—Ä–º–∞–Ω–∏—è –∏ –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏—è. –û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ —á–µ—Ç–∫–∏—Ö –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤ –ø–æ –≤–æ–ø—Ä–æ—Å—É –¥–∞–ª—å–Ω–µ–π—à–µ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –º–µ—Ä –ø–æ –±–æ—Ä—å–±–µ —Å –ø–æ–ª–∏–æ–º–∏–µ–ª–∏—Ç–æ–º —Å–æ–∑–¥–∞–µ—Ç –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—É—é –Ω–µ–æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ—Å—Ç—å.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, epidemic, vaccine"",
  ""impact"": ""high"",
  ""english"": ""Global charitable organizations and groups have offered to allocate $1.9 billion USD for polio eradication efforts. This funding will annually protect 370 million children from the virus. By 2026, the Global Polio Eradication Initiative's budget is expected to decrease by 30%, with a deficit of $1.7 billion USD by 2029. The reduction in financial support has been caused by countries like the US withdrawing from funding programs. Countries such as Germany and the UK have announced reductions in their contributions, creating additional uncertainty regarding future financing for polio eradication efforts.""
}"
2025-12-10T06:24:50+00:00,@pharmnewskz,6571,https://t.me/pharmnewskz/6571,"–ò—Ä–ª–∞–Ω–¥—Å–∫–∞—è Cosmo Pharmaceuticals –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∞ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –¥–≤—É—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π III —Ñ–∞–∑—ã 5-–ø—Ä–æ—Ü–µ–Ω—Ç–Ω–æ–≥–æ —Ä–∞—Å—Ç–≤–æ—Ä–∞ –∫–ª–∞—Å–∫–æ—Ç–µ—Ä–æ–Ω–∞, –ø–æ–∫–∞–∑—ã–≤–∞—é—â–∏–µ, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å–ø–æ—Å–æ–±–µ–Ω —Å–æ–≤–µ—Ä—à–∏—Ç—å —Ä–µ–≤–æ–ª—é—Ü–∏—é –≤ –ª–µ—á–µ–Ω–∏–∏ –≤—ã–ø–∞–¥–µ–Ω–∏—è –≤–æ–ª–æ—Å –ø–æ –º—É–∂—Å–∫–æ–º—É —Ç–∏–ø—É. –ü–∞—Ä–∞–ª–ª–µ–ª—å–Ω—ã–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –≤ –∫–æ—Ç–æ—Ä—ã—Ö —É—á–∞—Å—Ç–≤–æ–≤–∞–ª–∏ –ø–æ—á—Ç–∏ 1,5 —Ç—ã—Å. –º—É–∂—á–∏–Ω —Å –∞–Ω–¥—Ä–æ–≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–æ–π –∞–ª–æ–ø–µ—Ü–∏–µ–π –≤ –ï–≤—Ä–æ–ø–µ –∏ –°–®–ê, –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –∑–Ω–∞—á–∏–º–æ–µ —É–ª—É—á—à–µ–Ω–∏–µ —Ä–æ—Å—Ç–∞ –≤–æ–ª–æ—Å –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø–ª–∞—Ü–µ–±–æ. –í –æ–¥–Ω–æ–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ –æ—Ç–º–µ—á–µ–Ω–æ —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ –≤–æ–ª–æ—Å –≤ —Ü–µ–ª–µ–≤—ã—Ö –∑–æ–Ω–∞—Ö –Ω–∞ 539% –≤ —Ç–µ—á–µ–Ω–∏–µ –ø–æ–ª—É–≥–æ–¥–∞, —Ç–æ–≥–¥–∞ –∫–∞–∫ –≤ –¥—Ä—É–≥–æ–º ‚Äî –Ω–∞ 168%. –í –∫–æ–º–ø–∞–Ω–∏–∏ —É–≤–µ—Ä–µ–Ω—ã, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å ¬´–ø–µ—Ä–≤–æ–π –∏–Ω–Ω–æ–≤–∞—Ü–∏–µ–π –∑–∞ –±–æ–ª–µ–µ —á–µ–º 30 –ª–µ—Ç –≤ –æ–±–ª–∞—Å—Ç–∏ –ª–µ—á–µ–Ω–∏—è –∞–ª–æ–ø–µ—Ü–∏–∏ —É –º—É–∂—á–∏–Ω¬ª.","{""skip"": true}"
2025-12-10T06:24:05+00:00,@pharmnewskz,6570,https://t.me/pharmnewskz/6570,"–ü—Ä–∏–∫–∞–∑–æ–º ‚Ññ 512-–ù“ö –æ—Ç 14.11.2025 –ö–æ–º–∏—Ç–µ—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –ú–ó –†–ö –æ—Ç–∑—ã–≤–∞–µ—Ç —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Å—Ä–µ–¥—Å—Ç–≤–∞ ¬´–ö–ú-–ó–≤–µ—Ä–æ–±–æ–π, —Ñ–∏—Ç–æ-—á–∞–π¬ª, –†–ö-–õ–°-5‚Ññ014373, –¥–µ—Ä–∂–∞—Ç–µ–ª—å —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è –ü–ö ¬´–§–∏—Ä–º–∞ ¬´–ö–´–ó–´–õ–ú–ê–ô¬ª, –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω. –û—Å–Ω–æ–≤–∞–Ω–∏–µ: –ø–∏—Å—å–º–æ –ü–ö ¬´–§–∏—Ä–º–∞ ¬´–ö–´–ó–´–õ–ú–ê–ô¬ª ‚Ññ–ê0421/700 –æ—Ç 28 –æ–∫—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞. –ü—Ä–∏–∫–∞–∑ –ø–æ–¥–ø–∏—Å–∞–Ω –ü—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª–µ–º –ö–æ–º–∏—Ç–µ—Ç–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–µ—Å–ø—É–±–ª–∏–∫–∏ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω –ë. –î–∂—É—Å–∏–ø–æ–≤—ã–º.","{
  ""skip"": false,
  ""country"": ""–ö–∞–∑–∞—Ö—Å—Ç–∞–Ω"",
  ""topic"": ""registration, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Committee of Medical and Pharmaceutical Control in the Ministry of Health of Kazakhstan has revoked the registration certificate for the medicinal product 'KZ-Beetleberry, herbal tea', with registration number ROK-LS-5#014373. The revocation is due to a letter from the company 'Firma KYZYLMAI' dated October 28, 2025. The decision was signed by Chairman of the Committee of Medical and Pharmaceutical Control in the Ministry of Health of Kazakhstan B. Djusipov.""
}"
2025-12-10T13:24:46+00:00,@rncpharma,610,https://t.me/rncpharma/610,"ü§ì –ê–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∏–π –æ—Ç—á—ë—Ç –ø–æ —Ç–µ–∫—É—â–µ–º—É —Å–æ—Å—Ç–æ—è–Ω–∏—é —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ä–æ–∑–Ω–∏—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∑–∞ 1-3 –∫–≤. 2025 –≥. –ü—Ä–µ–∑–µ–Ω—Ç–∞—Ü–∏—è –±—ã–ª–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∞ –≤ —Ä–∞–º–∫–∞—Ö –¥–µ–ª–æ–≤–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã –≤—ã—Å—Ç–∞–≤–∫–∏ Pharmtech & Ingredients, –∫–æ—Ç–æ—Ä–∞—è –ø—Ä–æ—Ö–æ–¥–∏–ª–∞ —Å 25 –ø–æ 28 –Ω–æ—è–±—Ä—è 2025 –≥. –ù–µ–∫–æ—Ç–æ—Ä—ã–µ –¥–∞–Ω–Ω—ã–µ –∏–∑ –æ—Ç—á—ë—Ç–∞: ‚û°Ô∏è –†–æ–∑–Ω–∏—á–Ω—ã–π —Ä—ã–Ω–æ–∫ –≤–µ—Ç. –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –†–æ—Å—Å–∏–∏ –≤ 1-3 –∫–≤. 2025 –≥. –¥–æ—Å—Ç–∏–≥ 38,3 –º–ª—Ä–¥ —Ä—É–±. (–≤ —Ä–æ–∑–Ω–∏—á–Ω—ã—Ö —Ü–µ–Ω–∞—Ö, –≤–∫–ª—é—á–∞—è –ù–î–°), –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –ø—Ä–æ–¥–∞–∂ –¥–æ—Å—Ç–∏–≥–ª–∞ 16,1% ‚û°Ô∏è –û—Å–Ω–æ–≤–Ω–æ–π –≤–∫–ª–∞–¥ –≤ —Ä–∞–∑–≤–∏—Ç–∏–µ —Ä—ã–Ω–∫–∞ –≤–Ω–æ—Å–∏—Ç –æ–Ω–ª–∞–π–Ω –∫–∞–Ω–∞–ª, —á—Ç–æ –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ —Å—Ç–∞–≥–Ω–∞—Ü–∏–∏ –ø—Ä–æ–¥–∞–∂ –≤ –æ—Ñ–ª–∞–π–Ω —Ç–æ—á–∫–∞—Ö, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –∑–∞ —Å—á—ë—Ç –ø–µ—Ä–µ—Ç–æ–∫–∞ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã —Å—Ç–∞–≥–Ω–∏—Ä—É–µ—Ç —Å–ø—Ä–æ—Å –≤ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–π –≤–µ—Ç. —Ä–æ–∑–Ω–∏—Ü–µ –≤ –ú–æ—Å–∫–≤–µ –∏ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ ‚û°Ô∏è –î–æ–ª—è –æ–Ω–ª–∞–π–Ω –∫–∞–Ω–∞–ª–∞ –≤ —Ü–µ–ª–æ–º –ø–æ —Å—Ç—Ä–∞–Ω–µ –¥–æ—Å—Ç–∏–≥–ª–∞ 28,6% –≤ —Ä—É–±–ª—ë–≤–æ–º —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–µ, –≤ 2022 –≥. –æ–Ω–∞ –Ω–µ –ø—Ä–µ–≤—ã—à–∞–ª–∞ 8,9% ‚û°Ô∏è –†–æ—Å—Å–∏–π—Å–∫–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É—é—Ç –æ–ø–µ—Ä–µ–∂–∞—é—â—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø—Ä–æ–¥–∞–∂ (+37% –∫ 1-3 –∫–≤. 2025 –≥.), –ø—Ä–∏ —ç—Ç–æ–º –Ω–µ–º–µ—Ü–∫–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ø–æ—Ç–µ—Ä—è–ª–∏ 30% –æ–±–æ—Ä–æ—Ç–∞ ‚û°Ô∏è –ü–æ–∫–∞–∑–∞—Ç–µ–ª—å –∏–Ω—Ñ–ª—è—Ü–∏–∏ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 13,3% –∫ 1-3 –∫–≤. 2024 –≥., —Ü–µ–Ω—ã –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫—É—é –ø—Ä–æ–¥—É–∫—Ü–∏—é —Ä–∞—Å—Ç—É—Ç –±—ã—Å—Ç—Ä–µ–µ, —á–µ–º –Ω–∞ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—É—é ‚û°Ô∏è –ê—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç —Ä–æ–∑–Ω–∏—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ –≤–∫–ª—é—á–∞–µ—Ç 1883 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–∫–∏, –∑–∞ –≥–æ–¥ –∏—Ö –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å –Ω–∞ 28 –ø–æ–∑–∏—Ü–∏–π ‚û°Ô∏è –ê–±—Å–æ–ª—é—Ç–Ω—ã–º –ª–∏–¥–µ—Ä–æ–º —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –¥–µ–Ω–µ–∂–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂ —è–≤–ª—è–µ—Ç—Å—è ¬´–ó–æ—ç—Ç–∏—Å¬ª (–°–®–ê), –≤—Ç–æ—Ä—É—é —Å—Ç—Ä–æ—á–∫—É –∑–∞–Ω–∏–º–∞–µ—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∞—è ¬´–≠–∫–æ–ø—Ä–æ–º¬ª ‚û°Ô∏è –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É–µ—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è ¬´–í–µ—Ç—Ñ–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª –û—Ç—á—ë—Ç –ø–æ–¥–≥–æ—Ç–æ–≤–ª–µ–Ω –Ω–∞ –æ—Å–Ω–æ–≤–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –±–∞–∑—ã –¥–∞–Ω–Ω—ã—Ö ¬´–ê—É–¥–∏—Ç —Ä–æ–∑–Ω–∏—á–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω—ã—Ö –õ–ü –≤ –†–æ—Å—Å–∏–∏ (total sell out)¬ª ‚Äì –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–æ–¥—É–∫—Ç–∞ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –†–æ—Å—Å–∏–∏. #–≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–∏—è #–æ—Ç—á–µ—Ç ‚ö™Ô∏è –ü–æ–¥–ø–∏—Å–∞—Ç—å—Å—è –Ω–∞ RNC Pharma | ‚úâÔ∏è –ó–∞–∫–∞–∑–∞—Ç—å –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, demand, epidemic"",
  ""impact"": ""high"",
  ""english"": ""The report discusses the current state of the Russian retail market for veterinary drugs in Q1-Q3 2025. Key findings include a total retail sales value of 38.3 billion rubles (including VAT) and an annual growth rate of 16.1%. The online channel is driving stunted sales in traditional offline stores, particularly in Moscow and Saint Petersburg. Online market share has increased to 28.6% from 8.9% in 2022. Russian manufacturers have shown significant growth (+37%) compared to foreign brands which lost 30%. The report highlights the increasing inflation rate (13.3%) and rising prices of domestic products faster than imported ones. It also mentions a decrease in product variety from 1883 to 1855 brands over one year.""
}"
2025-12-10T08:06:01+00:00,@rncpharma,609,https://t.me/rncpharma/609,"‚ÜóÔ∏è –î–∂–µ–Ω–µ—Ä–∏–∫–∏ —Ä–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω–∞ –ø—Ä–æ—Å—Ç–∏–º—É–ª–∏—Ä–æ–≤–∞–ª–∏ –≤—ã—Å–æ–∫—É—é –Ω–∞—Ç—É—Ä–∞–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø—Ä–æ–¥–∞–∂ –∞–Ω—Ç–∏—Ç—Ä–æ–º–±–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –†–æ—Å—Å–∏–∏ –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma –≤ —è–Ω–≤–∞—Ä–µ-–æ–∫—Ç—è–±—Ä–µ 2025 –≥.: üìà 49,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π —Å–æ—Å—Ç–∞–≤–∏–ª –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –∞–Ω—Ç–∏—Ç—Ä–æ–º–±–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ (–≥—Ä—É–ø–ø–∞ B01 –ø–æ EphMRA) –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ (+6,3% –∫ —è–Ω–≤-–æ–∫—Ç ‚Äô24) üìà 58,3 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –±—ã–ª–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ (+1,7% –∫ —è–Ω–≤-–æ–∫—Ç ‚Äô24) üìä 57% –¥–µ–Ω–µ–∂–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂ –≤ –≥—Ä—É–ø–ø–µ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –ø—Ä—è–º—ã–µ –∏–Ω–≥–∏–±–∏—Ç–æ—Ä—ã —Ñ–∞–∫—Ç–æ—Ä–∞ –•–∞ (–ø–æ–¥–≥—Ä—É–ø–ø–∞ B01F) –î–∏–Ω–∞–º–∏–∫–∞ –ø–æ –≥—Ä—É–ø–ø–∞–º üìä üíä –ü—Ä—è–º—ã–µ –∏–Ω–≥–∏–±–∏—Ç–æ—Ä—ã —Ñ–∞–∫—Ç–æ—Ä–∞ –•–∞: +16% –≤ —É–ø–∞–∫. –∫ —è–Ω–≤-–æ–∫—Ç ‚Äô24 –°—É–º–º–∞—Ä–Ω—ã–π –µ–∂–µ–º–µ—Å—è—á–Ω—ã–π –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –ö—Å–∞—Ä–µ–ª—Ç–æ (¬´–ë–∞–π–µ—Ä –•–µ–ª—Å–∫–µ—Ä¬ª) —É–∂–µ –ø–æ –∏—Ç–æ–≥–∞–º –∞–≤–≥—É—Å—Ç–∞ 2025 –≥. –æ–ø–µ—Ä–µ–¥–∏–ª –æ–±—ä—ë–º —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ üíä –ì–µ–ø–∞—Ä–∏–Ω—ã: +9% –≤ —É–ø–∞–∫. –∫ —è–Ω–≤-–æ–∫—Ç ‚Äô24 üíä –ò–Ω–≥–∏–±–∏—Ç–æ—Ä—ã –∞–≥—Ä–µ–≥–∞—Ü–∏–∏ —Ç—Ä–æ–º–±–æ—Ü–∏—Ç–æ–≤: -2% –≤ —É–ø–∞–∫. –∫ —è–Ω–≤-–æ–∫—Ç ‚Äô24 –ë–æ–ª—å—à–µ –¥–∞–Ω–Ω—ã—Ö #—Ä–æ–∑–Ω–∏—Ü–∞ ‚ö™Ô∏è –ü–æ–¥–ø–∏—Å–∞—Ç—å—Å—è –Ω–∞ RNC Pharma | ‚úâÔ∏è –ó–∞–∫–∞–∑–∞—Ç—å –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""demand, shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The generics of rivaroxaban have stimulated a high natural sales growth for anticoagulant drugs on the Russian retail market. According to RNC Pharma data from January-October 2025: The revenue volume of anticoagulant drug group (B01 by EphMRA) in Russia's retail market was 49.3 billion rubles (+6.3% compared to January-October 2024). The number of units sold was 58.3 million (+1.7% compared to January-October 2024). 57% of the revenue volume in this group is accounted for by direct inhibitors of factor X (subgroup B01F). Sales dynamics: +16% per month in unit sales from January-October 2024. The monthly sales volume of generic Ksarelto (¬´Bayer Helkscher¬ª) has already exceeded the original drug's sales volume as of August 2025. #Retail""
}"
